BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
698204	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cn[nH]c1			351981	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(1H- pyrazol-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 1::US10822352, Comp No. 1::US9796741, cmp No. 1	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351981&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			91844719	386046389							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698205	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C31H24ClF2N7O3/c32-23-6-2-1-4-20(23)21-5-3-7-24(28(21)34)38-31(44)26-11-19(33)14-40(26)27(42)15-41-25-9-8-17(18-12-36-16-37-13-18)10-22(25)29(39-41)30(35)43/h1-10,12-13,16,19,26H,11,14-15H2,(H2,35,43)(H,38,44)/t19-,26+/m1/s1	QZVHYUYIGIMKDN-BCHFMIIMSA-N	351982	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 2::US10822352, Comp No. 2::US9796741, cmp No. 2	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351982&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323644	386046390							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698206	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(cc1)N1CCOCC1	InChI=1S/C30H29BrFN7O4/c31-25-2-1-3-26(34-25)35-30(42)24-15-20(32)16-38(24)27(40)17-39-23-9-6-19(14-22(23)28(36-39)29(33)41)18-4-7-21(8-5-18)37-10-12-43-13-11-37/h1-9,14,20,24H,10-13,15-17H2,(H2,33,41)(H,34,35,42)/t20-,24+/m1/s1	MKDACKDJTMRMBZ-YKSBVNFPSA-N	351984	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(4- morpholinophenyl)-1H- indazole-3-carboxamide::US10287301, Compound 3::US10822352, Comp No. 3::US9796741, cmp No. 3	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351984&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323710	386046392							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698207	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C25H21BrN8O3/c26-20-2-1-3-21(30-20)31-25(37)19-8-14-7-18(14)34(19)22(35)11-33-17-5-4-13(15-9-28-12-29-10-15)6-16(17)23(32-33)24(27)36/h1-6,9-10,12,14,18-19H,7-8,11H2,(H2,27,36)(H,30,31,37)/t14-,18-,19+/m1/s1	UEOSELNXXJLLHW-ZMYBRWDISA-N	351985	1-(2-((1R,3S,5R)-3-(6- bromopyridin-2- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 4::US10822352, Comp No. 4::US9796741, cmp No. 4	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351985&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323762	386046393							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698208	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C24H20BrFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-7-15(26)10-33(18)21(35)11-34-17-5-4-13(14-8-28-12-29-9-14)6-16(17)22(32-34)23(27)36/h1-6,8-9,12,15,18H,7,10-11H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	NGYKWUPOYMWBHQ-QAPCUYQASA-N	351986	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 5::US10822352, Comp No. 5::US9796741, cmp No. 5	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351986&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323584	386046394							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698209	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C32H25ClFN7O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(29(21)34)38-32(44)27-12-18-11-26(18)41(27)28(42)15-40-25-9-8-17(19-13-36-16-37-14-19)10-22(25)30(39-40)31(35)43/h1-10,13-14,16,18,26-27H,11-12,15H2,(H2,35,43)(H,38,44)/t18-,26-,27+/m1/s1	LNSXCQAIRPBMBA-PNKDDGGRSA-N	351987	1-(2-((1R,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 6::US10822352, Comp No. 6::US9796741, cmp No. 6	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351987&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323568	386046395							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698210	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ncccn1	InChI=1S/C32H25ClFN7O3/c33-22-7-2-1-5-19(22)20-6-3-8-23(28(20)34)38-32(44)26-15-18-14-25(18)41(26)27(42)16-40-24-10-9-17(31-36-11-4-12-37-31)13-21(24)29(39-40)30(35)43/h1-13,18,25-26H,14-16H2,(H2,35,43)(H,38,44)/t18-,25-,26+/m1/s1	RGFOOCIKWLGMQS-IHMJZKOGSA-N	351988	1-(2-((1R,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-2-yl)-1H- indazole-3-carboxamide::US10287301, Compound 7::US10822352, Comp No. 7::US9796741, cmp No. 7	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351988&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323567	386046396							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698211	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cncnc1	InChI=1S/C27H21F4N7O4/c28-23-17(2-1-3-21(23)42-27(29,30)31)35-26(41)20-8-14-7-19(14)38(20)22(39)11-37-18-5-4-13(15-9-33-12-34-10-15)6-16(18)24(36-37)25(32)40/h1-6,9-10,12,14,19-20H,7-8,11H2,(H2,32,40)(H,35,41)/t14-,19-,20+/m1/s1	DGNSLVWDCQMJID-XMCHAPAWSA-N	351989	1-(2-((1R,3S,5R)-3-(2- fluoro-3- (trifluoromethoxy) phenylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 8::US10822352, Comp No. 8::US9796741, cmp No. 8	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351989&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323611	386046397							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698212	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OC(F)(F)F)c2F)c2ccc(cc12)-c1cncnc1	InChI=1S/C26H20F5N7O4/c27-15-7-19(25(41)35-17-2-1-3-20(22(17)28)42-26(29,30)31)37(10-15)21(39)11-38-18-5-4-13(14-8-33-12-34-9-14)6-16(18)23(36-38)24(32)40/h1-6,8-9,12,15,19H,7,10-11H2,(H2,32,40)(H,35,41)/t15-,19+/m1/s1	LXCRMIOXUGVOFW-BEFAXECRSA-N	351990	1-(2-((2S,4R)-4-fluoro- 2-(2-fluoro-3- (trifluoromethoxy) phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyrimidin- 5-yl)-1H-indazole-3- carboxamide::US10287301, Compound 9::US10822352, Comp No. 9::US9796741, cmp No. 9	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351990&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323666	386046398							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698213	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C35H31ClF2N8O3/c36-26-8-2-1-6-23(26)24-7-5-9-27(31(24)38)42-34(49)29-15-22(37)18-45(29)30(47)19-46-28-11-10-20(14-25(28)32(43-46)33(39)48)21-16-40-35(41-17-21)44-12-3-4-13-44/h1-2,5-11,14,16-17,22,29H,3-4,12-13,15,18-19H2,(H2,39,48)(H,42,49)/t22-,29+/m1/s1	NEOHBOUCJJKPPP-MNNSJKJDSA-N	351991	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- (pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 10::US10822352, Comp No. 10::US9796741, cmp No. 10	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351991&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323740	386046399							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698214	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C29H28BrN9O3/c30-23-4-3-5-24(34-23)35-28(42)22-12-17-11-21(17)39(22)25(40)15-38-20-7-6-16(10-19(20)26(36-38)27(31)41)18-13-32-29(33-14-18)37-8-1-2-9-37/h3-7,10,13-14,17,21-22H,1-2,8-9,11-12,15H2,(H2,31,41)(H,34,35,42)/t17-,21-,22+/m1/s1	RJHGEHBGXZGCOG-YHYVQYDKSA-N	351992	1-(2-((1R,3S,5R)-3-(6- bromopyridin-2- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5-(2- (pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indazole-3-carboxamide::US10287301, Compound 11::US10822352, Comp No. 11::US9796741, cmp No. 11	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351992&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323686	386046400							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698215	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C32H24ClF3N6O3/c33-23-6-2-1-4-20(23)21-5-3-7-24(29(21)36)39-32(45)26-13-19(34)15-41(26)28(43)16-42-25-10-8-17(18-9-11-27(35)38-14-18)12-22(25)30(40-42)31(37)44/h1-12,14,19,26H,13,15-16H2,(H2,37,44)(H,39,45)/t19-,26+/m1/s1	QVKBQYCUNOUPDR-BCHFMIIMSA-N	351993	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(6- fluoropyridin-3-yl)-1H- indazole-3-carboxamide::US10287301, Compound 12::US10822352, Comp No. 12::US9796741, cmp No. 12	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351993&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323604	386046401							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698216	NC(=O)c1nn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(F)nc1	InChI=1S/C33H25ClF2N6O3/c34-23-6-2-1-4-20(23)21-5-3-7-24(30(21)36)39-33(45)27-14-19-13-26(19)42(27)29(43)16-41-25-10-8-17(18-9-11-28(35)38-15-18)12-22(25)31(40-41)32(37)44/h1-12,15,19,26-27H,13-14,16H2,(H2,37,44)(H,39,45)/t19-,26-,27+/m1/s1	SGRVMIDWOQDMOS-MERSGSKISA-N	351994	1-(2-((lR,3S,5R)-3-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-2- azabicyclo[3.1.0]hexan- 2-yl)-2-oxoethyl)-5-(6- fluoropyridin-3-yl)-1H- indazole-3-carboxamide::US10287301, Compound 13::US10822352, Comp No. 13::US9796741, cmp No. 13	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351994&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334293	386046402							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698217	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C26H22BrFN6O3/c1-15(35)20-12-33(21-6-5-16(7-19(20)21)17-9-29-14-30-10-17)13-25(36)34-11-18(28)8-22(34)26(37)32-24-4-2-3-23(27)31-24/h2-7,9-10,12,14,18,22H,8,11,13H2,1H3,(H,31,32,37)/t18-,22+/m1/s1	JZOXZNIXHYIHNY-GCJKJVERSA-N	351995	(2S,4R)-1-(2-(3-acetyl- 5-(pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 14::US10822352, Comp No. 14::US9796741, cmp No. 14	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351995&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323575	386046403							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698218	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cncnc1	InChI=1S/C34H27ClFN5O3/c1-19(42)26-16-40(29-10-9-20(11-25(26)29)22-14-37-18-38-15-22)17-32(43)41-30-12-21(30)13-31(41)34(44)39-28-8-4-6-24(33(28)36)23-5-2-3-7-27(23)35/h2-11,14-16,18,21,30-31H,12-13,17H2,1H3,(H,39,44)/t21-,30-,31+/m1/s1	XXCXEZAYRGRRQN-TUJMVGRMSA-N	351996	(1R,3S,5R)-2-(2-(3- acetyl-5-(pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 2-azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 15::US10822352, Comp No. 15::US9796741, cmp No. 15	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351996&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323642	386046404							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698219	CC(=O)N1CCN(CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H34ClF2N5O4/c1-21(44)28-19-42(31-11-10-24(17-27(28)31)41-14-12-40(13-15-41)22(2)45)20-33(46)43-18-23(37)16-32(43)35(47)39-30-9-5-7-26(34(30)38)25-6-3-4-8-29(25)36/h3-11,17,19,23,32H,12-16,18,20H2,1-2H3,(H,39,47)/t23-,32+/m1/s1	AOCGXFJEHSMMKC-HEIROHQZSA-N	351997	(2S,4R)-1-(2-(3-acetyl- 5-(4-acetylpiperazin-1- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 16::US10822352, Comp No. 16::US9796741, cmp No. 16	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351997&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323377	386046405							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698220	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cncnc1	InChI=1S/C27H23BrN6O3/c1-15(35)20-12-33(21-6-5-16(7-19(20)21)18-10-29-14-30-11-18)13-26(36)34-22-8-17(22)9-23(34)27(37)32-25-4-2-3-24(28)31-25/h2-7,10-12,14,17,22-23H,8-9,13H2,1H3,(H,31,32,37)/t17-,22-,23+/m1/s1	NSNZTQJAGQTRRO-ZQMYSKGWSA-N	351998	(1R,3S,5R)-2-(2-(3- acetyl-5-(pyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 17::US10822352, Comp No. 17::US9796741, cmp No. 17	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351998&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323764	386046406							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698221	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2cnc(cc12)-c1cncnc1	InChI=1S/C25H21ClF2N8O3/c26-17-3-1-2-13(22(17)28)8-33-25(39)19-4-15(27)10-35(19)21(37)11-36-20-9-32-18(14-6-30-12-31-7-14)5-16(20)23(34-36)24(29)38/h1-3,5-7,9,12,15,19H,4,8,10-11H2,(H2,29,38)(H,33,39)/t15-,19+/m1/s1	TWQHRWLRYLRCMK-BEFAXECRSA-N	351999	1-(2-((2S,4R)-2-(3- chloro-2- fluorobenzylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyrimidin-5-yl)-1H- pyrazolo[3,4- c]pyridine-3- carboxamide::US10287301, Compound 18::US10822352, Comp No. 18::US9796741, cmp No. 18	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=351999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=351999&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323607	386046407							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698222	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2cnc(cc12)-c1cncnc1	InChI=1S/C30H23ClF2N8O3/c31-21-6-2-1-4-18(21)19-5-3-7-22(27(19)33)38-30(44)24-8-17(32)13-40(24)26(42)14-41-25-12-37-23(16-10-35-15-36-11-16)9-20(25)28(39-41)29(34)43/h1-7,9-12,15,17,24H,8,13-14H2,(H2,34,43)(H,38,44)/t17-,24+/m1/s1	WYDLBVNRHQMQNW-OSPHWJPCSA-N	352000	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyrimidin-5-yl)-1H- pyrazolo[3,4- c]pyridine-3- carboxamide::US10287301, Compound 19::US10822352, Comp No. 19::US9796741, cmp No. 19	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352000&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323688	386046408							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698223	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H26ClF2N5O3/c1-19(42)26-17-40(29-10-9-20(13-25(26)29)21-11-12-37-38-15-21)18-31(43)41-16-22(35)14-30(41)33(44)39-28-8-4-6-24(32(28)36)23-5-2-3-7-27(23)34/h2-13,15,17,22,30H,14,16,18H2,1H3,(H,39,44)/t22-,30+/m1/s1	DDDZDWUGHJVCAJ-RCRUUEGKSA-N	352001	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acclyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 20::US10822352, Comp No. 20::US9796741, cmp No. 20	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352001&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323437	386046409							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698224	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C27H24BrFN6O4/c1-15(36)20-13-34(21-7-6-16(8-19(20)21)17-10-30-27(39-2)31-11-17)14-25(37)35-12-18(29)9-22(35)26(38)33-24-5-3-4-23(28)32-24/h3-8,10-11,13,18,22H,9,12,14H2,1-2H3,(H,32,33,38)/t18-,22+/m1/s1	PUGGYQZDKDFYBO-GCJKJVERSA-N	352002	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 21::US10822352, Comp No. 21::US9796741, cmp No. 21	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352002&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323560	386046410							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698225	CN1CCC(=CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C26H27BrFN7O3/c1-33-9-7-15(8-10-33)16-5-6-19-18(11-16)24(25(29)37)32-35(19)14-23(36)34-13-17(28)12-20(34)26(38)31-22-4-2-3-21(27)30-22/h2-7,11,17,20H,8-10,12-14H2,1H3,(H2,29,37)(H,30,31,38)/t17-,20+/m1/s1	QTOKQJXDHPSUCP-XLIONFOSSA-N	352003	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(1- methyl-1,2,3,6- tetrahydropyridin-4-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 22::US9796741, cmp No. 22	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352003&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323559	386046411							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698226	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClFN6O3/c1-15(35)20-13-33(21-6-5-16(9-19(20)21)17-7-8-29-30-11-17)14-25(36)34-12-18(28)10-22(34)26(37)32-24-4-2-3-23(27)31-24/h2-9,11,13,18,22H,10,12,14H2,1H3,(H,31,32,37)/t18-,22+/m1/s1	LOWVSOZSDFEWBG-GCJKJVERSA-N	352004	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- chloropyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 23::US10822352, Comp No. 23::US9796741, cmp No. 23	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352004&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323476	386046412							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698227	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-9-15(26)11-33(18)21(35)12-34-17-5-4-13(14-6-7-28-29-10-14)8-16(17)22(32-34)23(27)36/h1-8,10,15,18H,9,11-12H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	BINXWYYLRCFYQE-QAPCUYQASA-N	352005	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 24::US10822352, Comp No. 24::US9796741, cmp No. 24	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352005&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323705	386046413							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698228	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20BrFN8O3/c25-19-2-1-3-20(30-19)31-24(37)18-9-15(26)11-33(18)21(35)12-34-17-5-4-13(14-6-7-28-29-10-14)8-16(17)22(32-34)23(27)36/h1-8,10,15,18H,9,11-12H2,(H2,27,36)(H,30,31,37)/t15-,18+/m1/s1	GJSTWHZZGWGQOH-QAPCUYQASA-N	352006	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 25::US10822352, Comp No. 25::US9796741, cmp No. 25	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352006&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323746	386046414							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698229	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)N1CCCC1	InChI=1S/C37H33ClF2N6O3/c1-22(47)29-20-45(32-12-11-23(15-28(29)32)24-17-41-37(42-18-24)44-13-4-5-14-44)21-34(48)46-19-25(39)16-33(46)36(49)43-31-10-6-8-27(35(31)40)26-7-2-3-9-30(26)38/h2-3,6-12,15,17-18,20,25,33H,4-5,13-14,16,19,21H2,1H3,(H,43,49)/t25-,33+/m1/s1	ZAHRFVARVRLDEK-HPMVVLTCSA-N	352007	(2S,4R)-1-(2-(3-acetyl- 5-(2-(pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 26::US9796741, cmp No. 26	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352007&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323473	386046415							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698230	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C34H28ClF2N5O4/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)21-14-38-34(46-2)39-15-21)18-31(44)42-16-22(36)13-30(42)33(45)40-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,40,45)/t22-,30+/m1/s1	PLFKTJMZIVECGM-RCRUUEGKSA-N	352010	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 27::US10822352, Comp No. 27::US9796741, cmp No. 27	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352010&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323501	386046418							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698231	CC(=O)N1CCC(=CC1)c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(N)=O)c2c1	InChI=1S/C35H32ClF2N5O4/c1-20(44)41-13-11-21(12-14-41)22-9-10-30-26(15-22)27(34(39)46)18-42(30)19-32(45)43-17-23(37)16-31(43)35(47)40-29-8-4-6-25(33(29)38)24-5-2-3-7-28(24)36/h2-11,15,18,23,31H,12-14,16-17,19H2,1H3,(H2,39,46)(H,40,47)/t23-,31+/m1/s1	HFQGIBMSQGCGQJ-IPBJYNAHSA-N	352091	(2S,4R)-1-(2-(3-acetyl- 5-(1-acetyl-1,2,3,6- tetrahydropyridin-4-yl)- 1H-indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US9796741, cmp No. 28	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352091&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334296	386046496							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698232	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(N)=O)c2c1	InChI=1S/C33H27ClF2N6O4/c1-46-33-38-13-19(14-39-33)18-9-10-27-23(11-18)24(31(37)44)16-41(27)17-29(43)42-15-20(35)12-28(42)32(45)40-26-8-4-6-22(30(26)36)21-5-2-3-7-25(21)34/h2-11,13-14,16,20,28H,12,15,17H2,1H3,(H2,37,44)(H,40,45)/t20-,28+/m1/s1	HWPCQIMWXKPGEB-NGOKVRLYSA-N	352377	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methoxypyrimidin-5- yl)-1H-indazole-3- carboxamide::US9796741, cmp No. 29	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352377	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352377&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334297	386046753							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698233	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Cl)n3)nc(C(N)=O)c2c1	InChI=1S/C25H22ClFN8O4/c1-39-25-29-9-14(10-30-25)13-5-6-17-16(7-13)22(23(28)37)33-35(17)12-21(36)34-11-15(27)8-18(34)24(38)32-20-4-2-3-19(26)31-20/h2-7,9-10,15,18H,8,11-12H2,1H3,(H2,28,37)(H,31,32,38)/t15-,18+/m1/s1	YIOXCNSFXATOSG-QAPCUYQASA-N	352378	1-(2-((2S,4R)-2-(6- chloropyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methoxypyrimidin-5- yl)-1H-indazole-3- carboxamide::US10287301, Compound 30::US10822352, Comp No. 30::US9796741, cmp No. 30	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352378	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352378&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323582	386046754							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698234	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)c1ncccn1	InChI=1S/C37H34ClF2N7O3/c1-23(48)29-21-46(32-11-10-25(19-28(29)32)44-14-16-45(17-15-44)37-41-12-5-13-42-37)22-34(49)47-20-24(39)18-33(47)36(50)43-31-9-4-7-27(35(31)40)26-6-2-3-8-30(26)38/h2-13,19,21,24,33H,14-18,20,22H2,1H3,(H,43,50)/t24-,33+/m1/s1	IGGASGOYYVOTTI-IANOAQMISA-N	352379	(2S,4R)-1-(2-(3-acetyl- 5-(4-(pyrimidin-2- yl)piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 31::US10822352, Comp No. 31::US9796741, cmp No. 31	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352379	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352379&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323358	386046755							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698235	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)c1ncc(F)cn1	InChI=1S/C37H33ClF3N7O3/c1-22(49)29-20-47(32-10-9-25(16-28(29)32)45-11-13-46(14-12-45)37-42-17-24(40)18-43-37)21-34(50)48-19-23(39)15-33(48)36(51)44-31-8-4-6-27(35(31)41)26-5-2-3-7-30(26)38/h2-10,16-18,20,23,33H,11-15,19,21H2,1H3,(H,44,51)/t23-,33+/m1/s1	YHPWGSMIMXJFSC-NHRFMIRVSA-N	352488	(2S,4R)-1-(2-(3-acetyl- 5-(4-(5- fluoropyrimidin-2- yl)piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 32::US10822352, Comp No. 32::US9796741, cmp No. 32	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=352488	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=352488&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323744	386046794							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698236	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)N1CCN(CC1)S(C)(=O)=O	InChI=1S/C34H34ClF2N5O5S/c1-21(43)27-19-40(30-11-10-23(17-26(27)30)39-12-14-41(15-13-39)48(2,46)47)20-32(44)42-18-22(36)16-31(42)34(45)38-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-11,17,19,22,31H,12-16,18,20H2,1-2H3,(H,38,45)/t22-,31+/m1/s1	PRCPMFMTBRKSGU-UVDDSOTQSA-N	353069	(2S,4R)-1-(2-(3-acetyl- 5-(4-(methylsulfonyl) piperazin-1-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 33::US10822352, Comp No. 33::US9796741, cmp No. 33	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353069&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323721	386046808							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698237	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H27FN6O3S/c1-20(42)26-18-40(29-11-10-21(14-25(26)29)22-12-13-36-37-16-22)19-32(43)41-17-23(35)15-30(41)33(44)38-27-7-3-2-6-24(27)34-39-28-8-4-5-9-31(28)45-34/h2-14,16,18,23,30H,15,17,19H2,1H3,(H,38,44)/t23-,30+/m1/s1	FCPVSJBXKGLKSY-DJUQAAIZSA-N	353070	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(2- (benzo[d]thiazol-2- yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US9796741, cmp No. 34	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353070&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323748	386046809							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698238	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H25FN6O3S/c1-17(37)22-15-35(24-7-6-18(10-21(22)24)19-8-9-32-33-12-19)16-28(38)36-14-20(30)11-25(36)29(39)31-13-27-34-23-4-2-3-5-26(23)40-27/h2-10,12,15,20,25H,11,13-14,16H2,1H3,(H,31,39)/t20-,25+/m1/s1	UTHKOMZXWNHBID-NLFFAJNJSA-N	353071	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (benzo[d]thiazol-2- ylmethyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 35::US10822352, Comp No. 35::US9796741, cmp No. 35	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353071&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323621	386046810							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698239	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H26F3N5O3/c1-16(39)22-14-37(26-7-2-17(10-21(22)26)18-8-9-34-35-12-18)15-28(40)38-13-19(31)11-27(38)30(41)36-25-6-3-20-23(32)4-5-24(33)29(20)25/h2,4-5,7-10,12,14,19,25,27H,3,6,11,13,15H2,1H3,(H,36,41)/t19-,25?,27+/m1/s1	GVJWNYLEYQYIIK-PDPYFOFASA-N	353074	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (4,7-difluoro-2,3- dihydro-1H-inden-1- yl)-4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 36::US10822352, Comp No. 36::US9796741, cmp No. 36	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353074&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323658	386046813							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698240	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O3/c1-16(34)22-14-32(23-5-4-17(9-21(22)23)18-6-8-29-30-11-18)15-25(35)33-13-19(27)10-24(33)26(36)31-20-3-2-7-28-12-20/h2-9,11-12,14,19,24H,10,13,15H2,1H3,(H,31,36)/t19-,24+/m1/s1	PRTVFUIFKBTFDU-DVECYGJZSA-N	353155	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 37::US10822352, Comp No. 37::US9796741, cmp No. 37	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353155&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323636	386046894							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698241	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-6-5-18(10-22(23)24)19-7-9-31-32-12-19)16-26(36)34-14-20(28)11-25(34)27(37)30-13-21-4-2-3-8-29-21/h2-10,12,15,20,25H,11,13-14,16H2,1H3,(H,30,37)/t20-,25+/m1/s1	LPMPCWFSXZCJON-NLFFAJNJSA-N	353441	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-2- ylmethyl)pyrrolidine-2- carboxamide::US10287301, Compound 38::US10822352, Comp No. 38::US9796741, cmp No. 38	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353441	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353441&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323623	386047180							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698242	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-18-9-21(25(37)29-11-15-2-1-6-28-10-15)33(13-18)22(35)14-34-20-4-3-16(17-5-7-30-31-12-17)8-19(20)23(32-34)24(27)36/h1-8,10,12,18,21H,9,11,13-14H2,(H2,27,36)(H,29,37)/t18-,21+/m1/s1	LRWUUNJGJSVTAT-NQIIRXRSSA-N	353442	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-3- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 39::US10822352, Comp No. 39::US9796741, cmp No. 39	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353442	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353442&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323470	386047181							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698243	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-3-2-19(10-22(23)24)20-6-9-31-32-13-20)16-26(36)34-14-21(28)11-25(34)27(37)30-12-18-4-7-29-8-5-18/h2-10,13,15,21,25H,11-12,14,16H2,1H3,(H,30,37)/t21-,25+/m1/s1	WTXZETDBYHUBCP-BWKNWUBXSA-N	353443	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-4- ylmethyl)pyrrolidine-2- carboxamide::US10822352, Comp No. 40::US9796741, cmp No. 40	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353443	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353443&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323519	386047182							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698244	NC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-c2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H26FN7O3S/c34-21-14-28(32(44)38-25-6-2-1-5-22(25)33-39-26-7-3-4-8-29(26)45-33)41(16-21)30(42)18-40-17-24(31(35)43)23-13-19(9-10-27(23)40)20-11-12-36-37-15-20/h1-13,15,17,21,28H,14,16,18H2,(H2,35,43)(H,38,44)/t21-,28+/m1/s1	FKHFVGUWFDKCQZ-PIKZIKFNSA-N	353552	1-(2-((2S,4R)-2-(2- (benzo[d]thiazol-2- yl)phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US9796741, cmp No. 41	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=353552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=353552&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334302	386047291							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698245	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H22F4N6O4/c1-15(40)22-13-38(23-5-2-16(8-21(22)23)17-6-7-34-35-11-17)14-26(41)39-12-19(30)10-24(39)28(42)36-27-20-4-3-18(29(31,32)33)9-25(20)43-37-27/h2-9,11,13,19,24H,10,12,14H2,1H3,(H,36,37,42)/t19-,24+/m1/s1	WSSSSGFQWSDRSS-DVECYGJZSA-N	354133	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(6- (trifluoromethyl)benzo [d]isoxazol-3- yl)pyrrolidine-2- carboxamide::US10822352, Comp No. 42::US9796741, cmp No. 42	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354133&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323699	386047865							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698246	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCc3c2c(F)ccc3F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H24F3N7O3/c29-16-10-23(28(41)35-21-5-2-17-19(30)3-4-20(31)25(17)21)37(12-16)24(39)13-38-22-6-1-14(15-7-8-33-34-11-15)9-18(22)26(36-38)27(32)40/h1,3-4,6-9,11,16,21,23H,2,5,10,12-13H2,(H2,32,40)(H,35,41)/t16-,21?,23+/m1/s1	NCARUIHAVGZELZ-WRCFPPIZSA-N	354134	1-(2-((2S,4R)-2-(4,7- difluoro-2,3-dihydro- 1H-inden-1- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 43::US10822352, Comp No. 43::US9796741, cmp No. 43	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354134&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323736	386047866							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698247	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H25ClFN5O3/c1-17(36)24-15-34(25-6-5-19(10-23(24)25)20-7-8-32-33-13-20)16-27(37)35-14-22(30)11-26(35)28(38)31-12-18-3-2-4-21(29)9-18/h2-10,13,15,22,26H,11-12,14,16H2,1H3,(H,31,38)/t22-,26+/m1/s1	DNRIFSQFGNHDJQ-GJZUVCINSA-N	354135	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chlorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 44::US10822352, Comp No. 44::US9796741, cmp No. 44	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354135&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323743	386047867							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698248	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23ClFN7O3/c27-18-3-1-2-15(8-18)11-30-26(38)22-10-19(28)13-34(22)23(36)14-35-21-5-4-16(17-6-7-31-32-12-17)9-20(21)24(33-35)25(29)37/h1-9,12,19,22H,10-11,13-14H2,(H2,29,37)(H,30,38)/t19-,22+/m1/s1	ZXFRMUCAIOABLY-KNQAVFIVSA-N	354136	1-(2-((2S,4R)-2-(3- chlorobenzylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 45::US9796741, cmp No. 45	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354136&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323681	386047868							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698249	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H24ClF2N5O3/c1-16(37)24-14-35(25-3-2-18(8-23(24)25)19-4-5-33-34-12-19)15-27(38)36-13-22(31)10-26(36)28(39)32-11-17-6-20(29)9-21(30)7-17/h2-9,12,14,22,26H,10-11,13,15H2,1H3,(H,32,39)/t22-,26+/m1/s1	ZGNKOFKSDMNRBF-GJZUVCINSA-N	354137	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chloro-5-fluorobenzyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 46::US10822352, Comp No. 46::US9796741, cmp No. 46	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354137&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323558	386047869							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698250	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O3/c25-16-9-20(24(36)30-17-2-1-6-27-11-17)32(12-16)21(34)13-33-19-4-3-14(15-5-7-28-29-10-15)8-18(19)22(31-33)23(26)35/h1-8,10-11,16,20H,9,12-13H2,(H2,26,35)(H,30,36)/t16-,20+/m1/s1	YPDHKHHZRSZSQI-UZLBHIALSA-N	354138	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US9796741, cmp No. 47	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354138&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323706	386047870							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698251	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2C1=O	InChI=1S/C29H27FN8O4/c1-2-36-13-18-3-5-20(11-21(18)29(36)42)34-28(41)24-10-19(30)14-37(24)25(39)15-38-23-6-4-16(17-7-8-32-33-12-17)9-22(23)26(35-38)27(31)40/h3-9,11-12,19,24H,2,10,13-15H2,1H3,(H2,31,40)(H,34,41)/t19-,24+/m1/s1	LLTGCHLKDXDRGR-DVECYGJZSA-N	354139	1-(2-((2S,4R)-2-(2- ethyl-3-oxoisoindolin- 5-ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 48::US10822352, Comp No. 48::US9796741, cmp No. 48	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354139&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323683	386047871							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698252	CCN1Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)cc2C1=O	InChI=1S/C31H29FN6O4/c1-3-36-14-21-4-6-23(12-24(21)31(36)42)35-30(41)28-11-22(32)15-38(28)29(40)17-37-16-26(18(2)39)25-10-19(5-7-27(25)37)20-8-9-33-34-13-20/h4-10,12-13,16,22,28H,3,11,14-15,17H2,1-2H3,(H,35,41)/t22-,28+/m1/s1	COEXMOUYCYGEKN-DFHRPNOPSA-N	354141	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(2- ethyl-3-oxoisoindolin- 5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 49::US10822352, Comp No. 49::US9796741, cmp No. 49	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354141&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323731	386047873							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698253	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H21FN8O3S/c27-16-8-21(26(38)32-17-2-3-19-22(9-17)39-13-29-19)34(11-16)23(36)12-35-20-4-1-14(15-5-6-30-31-10-15)7-18(20)24(33-35)25(28)37/h1-7,9-10,13,16,21H,8,11-12H2,(H2,28,37)(H,32,38)/t16-,21+/m1/s1	RSQCUKUXQKMAMV-IERDGZPVSA-N	354142	1-(2-((2S,4R)-2- (benzo[d]thiazol-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 50::US10822352, Comp No. 50::US9796741, cmp No. 50	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354142&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323528	386047874							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698254	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCCC2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H32FN7O4/c32-22-14-26(31(42)36-24-7-4-8-27(24)43-18-19-5-2-1-3-6-19)38(16-22)28(40)17-39-25-10-9-20(21-11-12-34-35-15-21)13-23(25)29(37-39)30(33)41/h1-3,5-6,9-13,15,22,24,26-27H,4,7-8,14,16-18H2,(H2,33,41)(H,36,42)/t22-,24-,26+,27?/m1/s1	CWLLZRQDATYGCG-KAXQLXEHSA-N	354143	1-(2-((2S,4R)-2- ((1R,2S)-2- (benzyloxy)cyclopentyl carbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 51::US10822352, Comp No. 51::US9796741, cmp No. 51	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354143&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334304	386047875							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698255	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2nc3ccccc3s2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H23FN8O3S/c28-17-10-21(27(39)30-12-23-33-19-3-1-2-4-22(19)40-23)35(13-17)24(37)14-36-20-6-5-15(16-7-8-31-32-11-16)9-18(20)25(34-36)26(29)38/h1-9,11,17,21H,10,12-14H2,(H2,29,38)(H,30,39)/t17-,21+/m1/s1	IZYRRVJHKUUBKW-UTKZUKDTSA-N	354145	1-(2-((2S,4R)-2- (benzo[d]thiazol-2- ylmethylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 52::US10822352, Comp No. 52::US9796741, cmp No. 52	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354145&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323702	386047877							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698256	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3[nH]c(C)c(C)c3c2)c2ccc(cc12)-c1ccnnc1			354147	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (2,3-dimethyl-1H- indol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 53::US10822352, Comp No. 53::US9796741, cmp No. 53	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354147&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323511	386047879							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698257	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H31FN6O3S/c1-20(42)28-17-40(30-9-8-23(13-27(28)30)25-10-11-36-37-15-25)18-32(43)41-16-26(35)14-31(41)33(44)39-34-38-29(19-45-34)24-7-6-21-4-2-3-5-22(21)12-24/h6-13,15,17,19,26,31H,2-5,14,16,18H2,1H3,(H,38,39,44)/t26-,31+/m1/s1	ZGCDAXKPEVMWKD-NEEKEDPPSA-N	354149	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(4-(5,6,7,8- tetrahydronaphthalen- 2-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 54::US10822352, Comp No. 54::US9796741, cmp No. 54	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354149&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323531	386047881							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698258	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2ccc3CCCCc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H29FN8O3S/c33-23-13-27(31(44)38-32-37-25(17-45-32)21-6-5-18-3-1-2-4-19(18)11-21)40(15-23)28(42)16-41-26-8-7-20(22-9-10-35-36-14-22)12-24(26)29(39-41)30(34)43/h5-12,14,17,23,27H,1-4,13,15-16H2,(H2,34,43)(H,37,38,44)/t23-,27+/m1/s1	JUSZHPNKSOWIKM-KCWPFWIISA-N	354151	1-(2-((2S,4R)-4-fluoro- 2-(4-(5,6,7,8- tetrahydronaphthalen-2- yl)thiazol-2- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 55::US9796741, cmp No. 55	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354151&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323633	386047883							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698259	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ncsc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H23FN6O3S/c1-16(36)22-13-34(24-5-2-17(8-21(22)24)18-6-7-31-32-11-18)14-27(37)35-12-19(29)9-25(35)28(38)33-20-3-4-23-26(10-20)39-15-30-23/h2-8,10-11,13,15,19,25H,9,12,14H2,1H3,(H,33,38)/t19-,25+/m1/s1	IUPKZZXZHNYBFP-CLOONOSVSA-N	354152	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (benzo[d]thiazol-6-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 56::US10822352, Comp No. 56::US9796741, cmp No. 56	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354152&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323778	386047884							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698260	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(cs2)-c2c(C)nc3sccn23)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H25FN8O3S2/c1-16-27(38-7-8-43-30(38)34-16)23-15-44-29(35-23)36-28(42)25-10-20(31)12-39(25)26(41)14-37-13-22(17(2)40)21-9-18(3-4-24(21)37)19-5-6-32-33-11-19/h3-9,11,13,15,20,25H,10,12,14H2,1-2H3,(H,35,36,42)/t20-,25+/m1/s1	APRHJQJOENSTFN-NLFFAJNJSA-N	354153	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(4-(6- methylimidazo[2,1- b]thiazol-5-yl)thiazol-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 57::US10822352, Comp No. 57::US9796741, cmp No. 57	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354153&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323657	386047885							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698261	Cc1nc2sccn2c1-c1csc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)CC2N=C(C(N)=O)c3cc(ccc23)-c2ccnnc2)n1	InChI=1S/C29H24FN9O3S2/c1-14-25(38-6-7-43-29(38)34-14)21-13-44-28(36-21)37-27(42)22-9-17(30)12-39(22)23(40)10-20-18-3-2-15(16-4-5-32-33-11-16)8-19(18)24(35-20)26(31)41/h2-8,11,13,17,20,22H,9-10,12H2,1H3,(H2,31,41)(H,36,37,42)/t17-,20?,22+/m1/s1	LLZOOTXWYIGCGQ-BVWPGQGPSA-N	354154	1-(2-((2S,4R)-4-fluoro- 2-(4-(6- methylimidazo[2,1- b]thiazol-5-yl)thiazol-2- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US9796741, cmp No. 58	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354154&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			132033914	386047886							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698262	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccnc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H25FN6O3/c1-17(35)23-15-33(24-5-4-19(9-22(23)24)20-6-8-31-32-13-20)16-26(36)34-14-21(28)10-25(34)27(37)30-12-18-3-2-7-29-11-18/h2-9,11,13,15,21,25H,10,12,14,16H2,1H3,(H,30,37)/t21-,25+/m1/s1	HZJCSMACFHSXHU-BWKNWUBXSA-N	354155	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(pyridin-3- ylmethyl)pyrrolidine-2- carboxamide::US10287301, Compound 59::US10822352, Comp No. 59::US9796741, cmp No. 59	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354155&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323624	386047887							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698263	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccc(OCc3ccccc3)nc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H31FN6O4/c1-22(42)29-19-40(30-9-8-25(13-28(29)30)26-11-12-38-39-17-26)20-33(43)41-18-27(35)14-31(41)34(44)37-16-24-7-10-32(36-15-24)45-21-23-5-3-2-4-6-23/h2-13,15,17,19,27,31H,14,16,18,20-21H2,1H3,(H,37,44)/t27-,31+/m1/s1	INRWBJIHIQMKND-JOMNFKBKSA-N	354156	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- (benzyloxy)pyridin-2- yl)-4-fluoropyrrolidine- 2-carboxamide::US9796741, cmp No. 60	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354156	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354156&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334307	386047888							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698264	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CNC(=O)OCC3c4ccccc4-c4ccccc34)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C43H37FN6O5/c1-26(51)37-23-49(39-15-12-28(18-36(37)39)29-16-17-46-47-21-29)24-41(52)50-22-30(44)19-40(50)42(53)48-31-13-10-27(11-14-31)20-45-43(54)55-25-38-34-8-4-2-6-32(34)33-7-3-5-9-35(33)38/h2-18,21,23,30,38,40H,19-20,22,24-25H2,1H3,(H,45,54)(H,48,53)/t30-,40+/m1/s1	COKNEXNJLKGNRS-FRRBMJAGSA-N	354157	(9H-fluoren-9- yl)methyl(4-((2S,4R)- 1-(2-(3-acetyl-5- (pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoropyrrolidine-2- carboxamido) benzyl)carbamate::US10287301, Compound 61::US10822352, Comp No. 61::US9796741, cmp No. 61	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354157&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118346645	386047889							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698265	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cc(F)cc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClF2N7O3/c27-17-5-14(6-18(28)8-17)10-31-26(39)22-9-19(29)12-35(22)23(37)13-36-21-2-1-15(16-3-4-32-33-11-16)7-20(21)24(34-36)25(30)38/h1-8,11,19,22H,9-10,12-13H2,(H2,30,38)(H,31,39)/t19-,22+/m1/s1	OZPQAIYIVUYLTF-KNQAVFIVSA-N	354158	1-(2-((2S,4R)-2-(3- chloro-5- fluorobenzylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 62::US10822352, Comp No. 62::US9796741, cmp No. 62	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354158&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323700	386047890							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698266	Cc1[nH]c2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2c1C			354159	1-(2-((2S,4R)-2-(2,3- dimethyl-1H-indol-5- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 63::US10822352, Comp No. 63::US9796741, cmp No. 63	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354159&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323761	386047891							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698267	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H27FN6O5/c1-18(38)23-16-35(25-7-6-19(12-22(23)25)20-8-9-32-33-14-20)17-28(39)37-15-21(31)13-27(37)29(40)34-24-4-2-3-5-26(24)36-10-11-42-30(36)41/h2-9,12,14,16,21,27H,10-11,13,15,17H2,1H3,(H,34,40)/t21-,27+/m1/s1	PTWGEDNBHHMEIC-ZBLYBZFDSA-N	354160	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(2- oxooxazolidin-3- yl)phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 64::US10822352, Comp No. 64::US9796741, cmp No. 64	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354160&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323645	386047892							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698268	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2N2CCOC2=O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H25FN8O5/c29-18-12-23(27(40)33-20-3-1-2-4-22(20)35-9-10-42-28(35)41)36(14-18)24(38)15-37-21-6-5-16(17-7-8-31-32-13-17)11-19(21)25(34-37)26(30)39/h1-8,11,13,18,23H,9-10,12,14-15H2,(H2,30,39)(H,33,40)/t18-,23+/m1/s1	KQRUIHGEEHIGBM-JPYJTQIMSA-N	354161	1-(2-((2S,4R)-4-fluoro- 2-(2-(2-oxooxazolidin- 3-yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 65::US10822352, Comp No. 65::US9796741, cmp No. 65	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354161&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323615	386047893							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698269	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22ClFN6O3/c1-15(35)22-13-33(23-3-2-16(6-21(22)23)17-4-5-30-31-9-17)14-25(36)34-12-19(28)8-24(34)26(37)32-20-7-18(27)10-29-11-20/h2-7,9-11,13,19,24H,8,12,14H2,1H3,(H,32,37)/t19-,24+/m1/s1	RWERKAKVTXGVNX-DVECYGJZSA-N	354162	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- chloropyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 66::US10822352, Comp No. 66::US9796741, cmp No. 66	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354162&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323598	386047894							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698270	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H20ClFN8O3/c25-15-6-17(10-28-9-15)31-24(37)20-7-16(26)11-33(20)21(35)12-34-19-2-1-13(14-3-4-29-30-8-14)5-18(19)22(32-34)23(27)36/h1-6,8-10,16,20H,7,11-12H2,(H2,27,36)(H,31,37)/t16-,20+/m1/s1	WJWLVPUZJKKGAH-UZLBHIALSA-N	354163	1-(2-((2S,4R)-2-(5- chloropyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 67::US10822352, Comp No. 67::US9796741, cmp No. 67	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354163&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323752	386047895							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698271	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H22BrFN6O3/c1-15(35)22-13-33(23-3-2-16(6-21(22)23)17-4-5-30-31-9-17)14-25(36)34-12-19(28)8-24(34)26(37)32-20-7-18(27)10-29-11-20/h2-7,9-11,13,19,24H,8,12,14H2,1H3,(H,32,37)/t19-,24+/m1/s1	KBQQNSNKXFHXDY-DVECYGJZSA-N	354164	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- bromopyridin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 68::US10822352, Comp No. 68::US9796741, cmp No. 68	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354164&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323357	386047896							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698272	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H20Cl2FN9O3S/c28-18-3-1-14(8-19(18)29)26-35-36-27(43-26)34-25(42)21-9-16(30)11-38(21)22(40)12-39-20-4-2-13(15-5-6-32-33-10-15)7-17(20)23(37-39)24(31)41/h1-8,10,16,21H,9,11-12H2,(H2,31,41)(H,34,36,42)/t16-,21+/m1/s1	IEUBMOVRRHRDSO-IERDGZPVSA-N	354165	1-(2-((2S,4R)-2-(5-(3,4- dichlorophenyl)-1,3,4- thiadiazol-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 69::US10822352, Comp No. 69::US9796741, cmp No. 69	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354165&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323656	386047897							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698273	NCc1ccc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)cc1	InChI=1S/C26H25FN8O3/c27-18-10-22(26(38)32-19-4-1-15(11-28)2-5-19)34(13-18)23(36)14-35-21-6-3-16(17-7-8-30-31-12-17)9-20(21)24(33-35)25(29)37/h1-9,12,18,22H,10-11,13-14,28H2,(H2,29,37)(H,32,38)/t18-,22+/m1/s1	LUAIUZSIJQWRGK-GCJKJVERSA-N	354166	1-(2-((2S,4R)-2-(4- (aminomethyl) phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 70::US10822352, Comp No. 70::US9796741, cmp No. 70	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354166&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323753	386047898							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698274	Cc1ccnn1-c1ccccc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C29H26FN9O3/c1-17-8-11-34-39(17)24-5-3-2-4-22(24)35-29(42)25-13-20(30)15-37(25)26(40)16-38-23-7-6-18(19-9-10-32-33-14-19)12-21(23)27(36-38)28(31)41/h2-12,14,20,25H,13,15-16H2,1H3,(H2,31,41)(H,35,42)/t20-,25+/m1/s1	LORLHRLRYFPEEE-NLFFAJNJSA-N	354167	1-(2-((2S,4R)-4-fluoro- 2-(2-(5-methyl-1H- pyrazol-1- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 71::US10822352, Comp No. 71::US9796741, cmp No. 71	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354167&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323709	386047899							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698275	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccccc2-n2nccc2C)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H28FN7O3/c1-19-9-12-35-39(19)28-6-4-3-5-26(28)36-31(42)29-14-23(32)16-38(29)30(41)18-37-17-25(20(2)40)24-13-21(7-8-27(24)37)22-10-11-33-34-15-22/h3-13,15,17,23,29H,14,16,18H2,1-2H3,(H,36,42)/t23-,29+/m1/s1	XYIFZSRMWUSPIC-BTYSJIOQSA-N	354168	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(5-methyl- 1H-pyrazol-1- yl)phenyl)pyrrolidine- 2-carboxamide::US10287301, Compound 72::US10822352, Comp No. 72::US9796741, cmp No. 72	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354168&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323579	386047900							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698276	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(OCc3ccccc3)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H27FN8O4/c32-22-14-25(31(43)37-26-7-4-8-27(36-26)44-18-19-5-2-1-3-6-19)39(16-22)28(41)17-40-24-10-9-20(21-11-12-34-35-15-21)13-23(24)29(38-40)30(33)42/h1-13,15,22,25H,14,16-18H2,(H2,33,42)(H,36,37,43)/t22-,25+/m1/s1	HXYKQUZDRVMGIK-RDGATRHJSA-N	354169	1-(2-((2S,4R)-2-(6- (benzyloxy)pyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 73::US10822352, Comp No. 73::US9796741, cmp No. 73	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354169&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323654	386047901							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698277	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H36FN5O4/c1-22(41)28-19-39(30-12-11-24(15-27(28)30)25-13-14-36-37-17-25)20-33(42)40-18-26(35)16-31(40)34(43)38-29-9-5-6-10-32(29)44-21-23-7-3-2-4-8-23/h2-4,7-8,11-15,17,19,26,29,31-32H,5-6,9-10,16,18,20-21H2,1H3,(H,38,43)/t26-,29+,31+,32+/m1/s1	VDKAWHFQBJIXRL-PVKGFQCZSA-N	354170	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- ((1S,2S)-2- (benzyloxy)cyclohexyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 74::US10822352, Comp No. 74::US9796741, cmp No. 74	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354170&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323734	386047902							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698278	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3CC(C)(C)Oc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H30FN5O4/c1-18(38)25-16-36(26-7-5-19(10-24(25)26)21-8-9-33-34-14-21)17-29(39)37-15-22(32)11-27(37)30(40)35-23-6-4-20-13-31(2,3)41-28(20)12-23/h4-10,12,14,16,22,27H,11,13,15,17H2,1-3H3,(H,35,40)/t22-,27+/m1/s1	OHBNTBGQKUZLAO-AMGIVPHBSA-N	354171	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- (2,2-dimethyl-2,3- dihydrobenzofuran-6- yl)-4-fluoropyrrolidine- 2-carboxamide::US10287301, Compound 75::US10822352, Comp No. 75::US9796741, cmp No. 75	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354171&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323609	386047903							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698279	CC1(C)Cc2ccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)cc2O1	InChI=1S/C29H28FN7O4/c1-29(2)12-17-3-5-20(11-24(17)41-29)34-28(40)23-10-19(30)14-36(23)25(38)15-37-22-6-4-16(18-7-8-32-33-13-18)9-21(22)26(35-37)27(31)39/h3-9,11,13,19,23H,10,12,14-15H2,1-2H3,(H2,31,39)(H,34,40)/t19-,23+/m1/s1	HAWCJNPNNNWXOI-XXBNENTESA-N	354172	1-(2-((2S,4R)-2-(2,2- dimethyl-2,3- dihydrobenzofuran-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 76::US10822352, Comp No. 76::US9796741, cmp No. 76	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354172&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323625	386047904							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698280	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H34FN5O4/c1-21(40)27-18-38(29-11-10-23(14-26(27)29)24-12-13-35-36-16-24)19-32(41)39-17-25(34)15-30(39)33(42)37-28-8-5-9-31(28)43-20-22-6-3-2-4-7-22/h2-4,6-7,10-14,16,18,25,28,30-31H,5,8-9,15,17,19-20H2,1H3,(H,37,42)/t25-,28+,30+,31+/m1/s1	TVMIJUQREUIDRN-PEAQOHSKSA-N	354173	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N- ((1S,2S)-2- (benzyloxy)cyclopentyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 77::US10822352, Comp No. 77::US9796741, cmp No. 77	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354173	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354173&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323687	386047905							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698281	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2OCc2ccccc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H34FN7O4/c33-23-15-27(32(43)37-25-8-4-5-9-28(25)44-19-20-6-2-1-3-7-20)39(17-23)29(41)18-40-26-11-10-21(22-12-13-35-36-16-22)14-24(26)30(38-40)31(34)42/h1-3,6-7,10-14,16,23,25,27-28H,4-5,8-9,15,17-19H2,(H2,34,42)(H,37,43)/t23-,25+,27+,28+/m1/s1	FTRCCOQGAJYPMT-DEKSYSNASA-N	354174	1-(2-((2S,4R)-2- ((1S),2S)-2-(benzyloxy) cyclohexylcarbamoyl)- 4-fluoropyrrolidin-1- yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 78::US10822352, Comp No. 78::US9796741, cmp No. 78	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354174	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354174&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118334313	386047906							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698282	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C20H20FN7O3/c1-23-20(31)16-7-13(21)9-27(16)17(29)10-28-15-3-2-11(12-4-5-24-25-8-12)6-14(15)18(26-28)19(22)30/h2-6,8,13,16H,7,9-10H2,1H3,(H2,22,30)(H,23,31)/t13-,16+/m1/s1	NPAMWFHESCJZMB-CJNGLKHVSA-N	354175	1-(2-((2S,4R)-4-fluoro- 2-(methylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 79::US10822352, Comp No. 79::US9796741, cmp No. 79	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354175	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354175&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323556	386047907							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698283	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H29ClFN5O4/c1-19(43)26-17-41(29-11-10-20(12-25(26)29)22-15-38-35(46-2)39-16-22)18-32(44)42-30-13-21(30)14-31(42)34(45)40-28-9-5-7-24(33(28)37)23-6-3-4-8-27(23)36/h3-12,15-17,21,30-31H,13-14,18H2,1-2H3,(H,40,45)/t21-,30-,31+/m1/s1	LXBXOMDOYZSHFZ-TUJMVGRMSA-N	354176	(1R,3S,5R)-2-(2-(3-  acetyl-5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 2-azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 80::US10822352, Comp No. 80::US9796741, cmp No. 80	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354176	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354176&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323539	386047908							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698284	COc1ncc(cn1)-c1ccc2n(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C28H25BrN6O4/c1-15(36)20-13-34(21-7-6-16(8-19(20)21)18-11-30-28(39-2)31-12-18)14-26(37)35-22-9-17(22)10-23(35)27(38)33-25-5-3-4-24(29)32-25/h3-8,11-13,17,22-23H,9-10,14H2,1-2H3,(H,32,33,38)/t17-,22-,23+/m1/s1	LBKYMXLWZMGZGL-ZQMYSKGWSA-N	354177	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 81::US10822352, Comp No. 81::US9796741, cmp No. 81	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354177	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354177&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323673	386047909							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698285	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(nc1)C#N	InChI=1S/C27H21BrFN7O3/c1-15(37)20-13-35(21-6-5-16(7-19(20)21)17-10-31-25(9-30)32-11-17)14-26(38)36-12-18(29)8-22(36)27(39)34-24-4-2-3-23(28)33-24/h2-7,10-11,13,18,22H,8,12,14H2,1H3,(H,33,34,39)/t18-,22+/m1/s1	BZDCGIOHHRKHLK-GCJKJVERSA-N	354178	(2S,4R)-1-(2-(3-acetyl- 5-(2-cyanopyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 82::US10822352, Comp No. 82::US9796741, cmp No. 82	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354178	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354178&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323708	386047910							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698286	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(F)nc1	InChI=1S/C26H21BrF2N6O3/c1-14(36)19-12-34(20-6-5-15(7-18(19)20)16-9-30-26(29)31-10-16)13-24(37)35-11-17(28)8-21(35)25(38)33-23-4-2-3-22(27)32-23/h2-7,9-10,12,17,21H,8,11,13H2,1H3,(H,32,33,38)/t17-,21+/m1/s1	ODUZXFLSXMMLEF-UTKZUKDTSA-N	354180	(2S,4R)-1-(2-(3-acetyl- 5-(2-fluoropyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 83::US10822352, Comp No. 83::US9796741, cmp No. 83	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354180	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354180&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323597	386047912							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698287	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24BrFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23+/m1/s1	HJOQHGVZGIOBFX-XXBNENTESA-N	354181	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 84::US10822352, Comp No. 84::US9796741, cmp No. 84	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354181	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354181&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323714	386047913							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698288	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(CN)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H27FN6O3/c1-17(36)24-15-34(25-7-4-19(10-23(24)25)20-8-9-31-32-13-20)16-27(37)35-14-21(29)11-26(35)28(38)33-22-5-2-18(12-30)3-6-22/h2-10,13,15,21,26H,11-12,14,16,30H2,1H3,(H,33,38)/t21-,26+/m1/s1	IQZCRKZSXCYGON-RLWLMLJZSA-N	354182	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(4- (aminomethyl)phenyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 85::US10822352, Comp No. 85::US9796741, cmp No. 85	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354182	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354182&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323692	386047914							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698289	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(cc12)-c1ccnnc1			354183	1-(2-((2S,4R)-2-(1H- indazol-6- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 86::US10822352, Comp No. 86::US9796741, cmp No. 86	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354183	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354183&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208185	386047915							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698290	CNC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C22H22FN5O3/c1-13(29)18-11-27(12-21(30)28-10-16(23)8-20(28)22(31)24-2)19-4-3-14(7-17(18)19)15-5-6-25-26-9-15/h3-7,9,11,16,20H,8,10,12H2,1-2H3,(H,24,31)/t16-,20+/m1/s1	KAWNASMRXRUOPO-UZLBHIALSA-N	354184	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N- methylpyrrolidine-2- carboxamide::US10287301, Compound 87::US10822352, Comp No. 87::US9796741, cmp No. 87	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354184	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354184&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323456	386047916							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698291	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21ClFN7O3/c1-14(35)19-12-33(20-3-2-15(6-18(19)20)16-4-5-29-30-8-16)13-24(36)34-11-17(27)7-21(34)25(37)32-23-10-28-9-22(26)31-23/h2-6,8-10,12,17,21H,7,11,13H2,1H3,(H,31,32,37)/t17-,21+/m1/s1	HPLFDPFYFFETIZ-UTKZUKDTSA-N	354185	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- chloropyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 88::US10822352, Comp No. 88::US9796741, cmp No. 88	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354185	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354185&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323570	386047917							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698292	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Cl)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19ClFN9O3/c24-18-8-27-9-19(30-18)31-23(37)17-6-14(25)10-33(17)20(35)11-34-16-2-1-12(13-3-4-28-29-7-13)5-15(16)21(32-34)22(26)36/h1-5,7-9,14,17H,6,10-11H2,(H2,26,36)(H,30,31,37)/t14-,17+/m1/s1	OGHSJACEKHZFSR-PBHICJAKSA-N	354187	1-(2-((2S,4R)-2-(6- chloropyrazin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 89::US9796741, cmp No. 89	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354187	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354187&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323739	386047919							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698293	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19BrFN9O3/c24-18-8-27-9-19(30-18)31-23(37)17-6-14(25)10-33(17)20(35)11-34-16-2-1-12(13-3-4-28-29-7-13)5-15(16)21(32-34)22(26)36/h1-5,7-9,14,17H,6,10-11H2,(H2,26,36)(H,30,31,37)/t14-,17+/m1/s1	STTIZKZGCUGBCW-PBHICJAKSA-N	354188	1-(2-((2S,4R)-2-(5- bromopyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 128::US9796741, cmp No. 128::US9796741, cmp No. 90	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354188&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323639	386047920							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698294	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc(F)c(c2)-c2nnc3CCCCCn23)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H30F2N10O3/c33-20-13-26(32(47)38-21-6-7-24(34)22(14-21)31-40-39-27-4-2-1-3-11-42(27)31)43(16-20)28(45)17-44-25-8-5-18(19-9-10-36-37-15-19)12-23(25)29(41-44)30(35)46/h5-10,12,14-15,20,26H,1-4,11,13,16-17H2,(H2,35,46)(H,38,47)/t20-,26+/m1/s1	LAUIADBXSLVZKN-IBVKSMDESA-N	354189	1-(2-((2S,4R)-4-fluoro- 2-(4-fluoro-3-(6,7,8,9- tetrahydro-5H- [1,2,4]triazolo[4,3- a]azepin-3- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 91::US9796741, cmp No. 91	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354189	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354189&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323682	386047921							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698295	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H20ClF4N7O3/c27-17-2-1-3-18(22(17)26(29,30)31)35-25(41)20-9-15(28)11-37(20)21(39)12-38-19-5-4-13(14-6-7-33-34-10-14)8-16(19)23(36-38)24(32)40/h1-8,10,15,20H,9,11-12H2,(H2,32,40)(H,35,41)/t15-,20+/m1/s1	CKRJJZGVVRUTRB-QRWLVFNGSA-N	354190	1-(2-((2S,4R)-2-(3- chloro-2- (trifluoromethyl) phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 93::US9796741, cmp No. 93	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354190	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354190&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323675	386047922							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698296	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(cc12)-c1ccnnc1			354191	1-(2-((2S,4R)-2-(3-(2,4- dichlorophenyl)-1H- pyrazol-4- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 94::US10822352, Comp No. 94::US9796741, cmp No. 94	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354191	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354191&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208186	386047923							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698297	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H24ClFN8O3/c1-17(40)22-13-37(25-6-5-18(9-21(22)25)19-7-8-33-34-11-19)14-27(41)38-12-20(31)10-26(38)29(42)36-24-4-2-3-23(30)28(24)39-16-32-15-35-39/h2-9,11,13,15-16,20,26H,10,12,14H2,1H3,(H,36,42)/t20-,26+/m1/s1	SJLOEAHYJLTXLE-IBVKSMDESA-N	354192	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chloro-2-(1H-1,2,4- triazol-1-yl)phenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 95::US10822352, Comp No. 95::US9796741, cmp No. 95	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354192	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354192&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323507	386047924							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698298	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2-n2cncn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H22ClFN10O3/c28-19-2-1-3-20(25(19)39-14-31-13-34-39)35-27(42)22-9-17(29)11-37(22)23(40)12-38-21-5-4-15(16-6-7-32-33-10-16)8-18(21)24(36-38)26(30)41/h1-8,10,13-14,17,22H,9,11-12H2,(H2,30,41)(H,35,42)/t17-,22+/m1/s1	LEGRAROFLIPOMP-VGSWGCGISA-N	354193	1-(2-((2S,4R)-2-(3- chloro-2-(1H-1,2,4- triazol-1- yl)phenylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 96::US10822352, Comp No. 96::US9796741, cmp No. 96	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354193	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354193&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323565	386047925							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698299	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nc3nc(nn23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H23F4N9O3/c1-14-7-23(41-27(35-14)37-26(38-41)28(30,31)32)36-25(44)22-9-18(29)11-40(22)24(43)13-39-12-20(15(2)42)19-8-16(3-4-21(19)39)17-5-6-33-34-10-17/h3-8,10,12,18,22H,9,11,13H2,1-2H3,(H,36,44)/t18-,22+/m1/s1	MADDTEKZBMTHBB-GCJKJVERSA-N	354194	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- yl)pyrrolidine-2- carboxamide::US10287301, Compound 97::US10822352, Comp No. 97::US9796741, cmp No. 97	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354194	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354194&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323641	386047926							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698300	CN1C=NC=[N]1c1ccccc1NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C28H26FN10O3/c1-36-15-31-16-39(36)23-5-3-2-4-21(23)34-28(42)24-11-19(29)13-37(24)25(40)14-38-22-7-6-17(18-8-9-32-33-12-18)10-20(22)26(35-38)27(30)41/h2-10,12,15-16,19,24H,11,13-14H2,1H3,(H2,30,41)(H,34,42)/t19-,24+/m1/s1	TYYZXIUGDKOLFS-DVECYGJZSA-N	354195	1-(2-((2S,4R)-4-fluoro- 2-(2-(4-methyl-4H- 1,2,4-triazol-3- yl)phenylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US9796741, cmp No. 98	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354195	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354195&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			123581045	386047927							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698301	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)28(41)35-29-34-27(36-42-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,35,36,41)/t19-,25+/m1/s1	YTVVKXFKGQTQKH-CLOONOSVSA-N	354196	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (2-chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 99::US10822352, Comp No. 99::US9796741, cmp No. 99	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354196	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354196&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323715	386047928							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698302	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccccc1Cl	InChI=1S/C28H23BrClFN4O3/c1-16(36)21-14-34(23-10-9-17(11-20(21)23)19-5-2-3-6-22(19)30)15-27(37)35-13-18(31)12-24(35)28(38)33-26-8-4-7-25(29)32-26/h2-11,14,18,24H,12-13,15H2,1H3,(H,32,33,38)/t18-,24+/m1/s1	ZRAHPETXANGXSZ-KOSHJBKYSA-N	354197	(2S,4R)-1-(2-(3-acetyl- 5-(2-chlorophenyl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 100::US10822352, Comp No. 100::US9796741, cmp No. 100	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354197	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354197&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323742	386047929							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698303	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)nc(C(N)=O)c2c1	InChI=1S/C25H22BrFN8O3/c1-13-29-9-15(10-30-13)14-5-6-18-17(7-14)23(24(28)37)33-35(18)12-22(36)34-11-16(27)8-19(34)25(38)32-21-4-2-3-20(26)31-21/h2-7,9-10,16,19H,8,11-12H2,1H3,(H2,28,37)(H,31,32,38)/t16-,19+/m1/s1	QIFSWMBIFIBWOP-APWZRJJASA-N	354198	1-(2-((2S,4R)-2-(6- bromopyridin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methylpyrimidin-5-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 101::US10822352, Comp No. 278::US9796741, cmp No. 101	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354198	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354198&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323747	386047930							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698304	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28ClF2N5O3/c1-19(43)27-17-41(30-11-10-21(12-26(27)30)22-14-38-20(2)39-15-22)18-32(44)42-16-23(36)13-31(42)34(45)40-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-12,14-15,17,23,31H,13,16,18H2,1-2H3,(H,40,45)/t23-,31+/m1/s1	RCYMDCKZXLSTRB-IPBJYNAHSA-N	354199	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 163::US10822352, Comp No. 102::US9796741, cmp No. 102	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354199	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354199&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323574	386047931							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698305	Cc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)nc(C(N)=O)c2c1	InChI=1S/C32H26ClF2N7O3/c1-17-37-13-19(14-38-17)18-9-10-26-23(11-18)30(31(36)44)40-42(26)16-28(43)41-15-20(34)12-27(41)32(45)39-25-8-4-6-22(29(25)35)21-5-2-3-7-24(21)33/h2-11,13-14,20,27H,12,15-16H2,1H3,(H2,36,44)(H,39,45)/t20-,27+/m1/s1	BNMJGBHJVHZWSP-HRFSGMKKSA-N	354200	1-(2-((2S,4R)-2-(2'- chloro-2- fluorobiphenyl-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5-(2- methylpyrimidin-5-yl)- 1H-indazole-3- carboxamide::US10287301, Compound 103::US10822352, Comp No. 103::US9796741, cmp No. 103	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354200	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354200&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323759	386047932							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698306	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CN(Cc23)c2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H28FN9O3/c33-22-13-27(32(45)38-25-5-3-4-21-15-40(17-24(21)25)28-6-1-2-10-35-28)41(16-22)29(43)18-42-26-8-7-19(20-9-11-36-37-14-20)12-23(26)30(39-42)31(34)44/h1-12,14,22,27H,13,15-18H2,(H2,34,44)(H,38,45)/t22-,27+/m1/s1	SBEBZZCZYKGUPC-AMGIVPHBSA-N	354201	1-(2-((2S,4R)-4-fluoro- 2-(2-(pyridin-2- yl)isoindolin-4- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 104::US10822352, Comp No. 104::US9796741, cmp No. 104	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354201	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354201&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323648	386047933							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698307	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc3CN(Cc23)c2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H30FN7O3/c1-21(43)27-18-40(30-9-8-22(13-26(27)30)23-10-12-37-38-15-23)20-33(44)42-17-25(35)14-31(42)34(45)39-29-6-4-5-24-16-41(19-28(24)29)32-7-2-3-11-36-32/h2-13,15,18,25,31H,14,16-17,19-20H2,1H3,(H,39,45)/t25-,31+/m1/s1	RKUCOGVAXNDWRC-NJHZRGNWSA-N	354202	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(pyridin-2- yl)isoindolin-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 105::US10822352, Comp No. 105::US9796741, cmp No. 105	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354202	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354202&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323526	386047934							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698308	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C34H30F2N6O3S/c1-19(43)26-17-41(29-10-7-21(13-25(26)29)22-11-12-37-38-15-22)18-31(44)42-16-24(36)14-30(42)33(45)39-27-3-2-4-28-32(27)46-34(40-28)20-5-8-23(35)9-6-20/h5-13,15,17,24,27,30H,2-4,14,16,18H2,1H3,(H,39,45)/t24-,27?,30+/m1/s1	FEROJIGCHZJALH-JVVZTMHVSA-N	354203	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-(4- fluorophenyl)-4,5,6,7- tetrahydrobenzo[d] thiazol-7-yl) pyrrolidine-2- carboxamide::US10287301, Compound 106::US10822352, Comp No. 106::US9796741, cmp No. 106	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354203	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354203&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323679	386047935							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698309	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCc3nc(sc23)-c2ccc(F)cc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H28F2N8O3S/c33-20-7-4-17(5-8-20)32-39-24-3-1-2-23(29(24)46-32)38-31(45)26-13-21(34)15-41(26)27(43)16-42-25-9-6-18(19-10-11-36-37-14-19)12-22(25)28(40-42)30(35)44/h4-12,14,21,23,26H,1-3,13,15-16H2,(H2,35,44)(H,38,45)/t21-,23?,26+/m1/s1	XGFKZXWWKPCNIT-HEEQAANPSA-N	354204	1-(2-((2S,4R)-4-fluoro- 2-(2-(4-fluorophenyl)- 4,5,6,7- tetrahydrobenzo[d] thiazol-7- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 107::US10822352, Comp No. 107::US9796741, cmp No. 107	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354204	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354204&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323784	386047936							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698310	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21BrFN7O3/c1-14(35)20-12-33(21-3-2-15(6-19(20)21)16-4-5-30-31-8-16)13-23(36)34-11-18(27)7-22(34)24(37)32-25-28-9-17(26)10-29-25/h2-6,8-10,12,18,22H,7,11,13H2,1H3,(H,28,29,32,37)/t18-,22+/m1/s1	LFALWBRMCSKFCW-GCJKJVERSA-N	354205	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- bromopyrimidin-2-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 108::US10822352, Comp No. 108::US9796741, cmp No. 108	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354205	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354205&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323693	386047937							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698311	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ncc(Br)cn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19BrFN9O3/c24-14-8-27-23(28-9-14)31-22(37)18-6-15(25)10-33(18)19(35)11-34-17-2-1-12(13-3-4-29-30-7-13)5-16(17)20(32-34)21(26)36/h1-5,7-9,15,18H,6,10-11H2,(H2,26,36)(H,27,28,31,37)/t15-,18+/m1/s1	IJUQRHNVXVLJCD-QAPCUYQASA-N	354207	1-(2-((2S,4R)-2-(5- bromopyrimidin-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 109::US10822352, Comp No. 109::US9796741, cmp No. 109	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354207	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354207&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323593	386047939							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698312	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C31H26FN5O3/c1-19(38)27-17-36(28-9-7-22(13-26(27)28)23-10-11-33-34-15-23)18-30(39)37-16-24(32)14-29(37)31(40)35-25-8-6-20-4-2-3-5-21(20)12-25/h2-13,15,17,24,29H,14,16,18H2,1H3,(H,35,40)/t24-,29+/m1/s1	MKKSPXFVUCKSBN-GIGWZHCTSA-N	354208	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(naphthalen-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 110::US10822352, Comp No. 110::US9796741, cmp No. 110	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354208	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354208&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323653	386047940							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698313	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@H]2CCCC[C@@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H30FN5O4/c1-16(34)21-14-32(23-7-6-17(10-20(21)23)18-8-9-29-30-12-18)15-26(36)33-13-19(28)11-24(33)27(37)31-22-4-2-3-5-25(22)35/h6-10,12,14,19,22,24-25,35H,2-5,11,13,15H2,1H3,(H,31,37)/t19-,22+,24+,25+/m1/s1	BYUPNBICXSMYJH-FISOAXRRSA-N	354209	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-((1S,2S)-2- hydroxycyclohexyl) pyrrolidine-2- carboxamide::US10287301, Compound 111::US10822352, Comp No. 111::US9796741, cmp No. 111	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354209	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354209&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323606	386047941							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698314	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc3cc(ccc23)C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H20F4N8O4/c28-16-9-20(26(42)35-25-17-3-2-15(27(29,30)31)8-21(17)43-37-25)38(11-16)22(40)12-39-19-4-1-13(14-5-6-33-34-10-14)7-18(19)23(36-39)24(32)41/h1-8,10,16,20H,9,11-12H2,(H2,32,41)(H,35,37,42)/t16-,20+/m1/s1	CGKIVYROXKFNRV-UZLBHIALSA-N	354213	1-(2-((2S,4R)-4-fluoro- 2-(6-(trifluoromethyl) benzo[d]isoxazol-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 112::US9796741, cmp No. 112	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354213	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354213&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323766	386047945							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698315	Cc1cc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)n2nc(nc2n1)C(F)(F)F	InChI=1S/C26H21F4N11O3/c1-12-6-19(41-25(34-12)36-24(38-41)26(28,29)30)35-23(44)18-8-15(27)10-39(18)20(42)11-40-17-3-2-13(14-4-5-32-33-9-14)7-16(17)21(37-40)22(31)43/h2-7,9,15,18H,8,10-11H2,1H3,(H2,31,43)(H,35,44)/t15-,18+/m1/s1	GTZJFYJAQQYUNL-QAPCUYQASA-N	354214	1-(2-((2S,4R)-4-fluoro- 2-(5-methyl-2- (trifluoromethyl)- [1,2,4]triazolo[1,5- a]pyrimidin-7- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 113::US9796741, cmp No. 113	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354214	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354214&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323546	386047946							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698316	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-19-4-2-1-3-17(19)25-33-27(42-36-25)34-26(41)21-10-16(29)12-37(21)22(39)13-38-20-6-5-14(15-7-8-31-32-11-15)9-18(20)23(35-38)24(30)40/h1-9,11,16,21H,10,12-13H2,(H2,30,40)(H,33,34,36,41)/t16-,21+/m1/s1	ZAIOBGNYNNPPIX-IERDGZPVSA-N	354215	1-(2-((2S,4R)-2-(3-(2- chlorophenyl)-1,2,4- thiadiazol-5- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 114::US10822352, Comp No. 114::US9796741, cmp No. 114	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354215	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354215&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323787	386047947							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698317	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-19-4-2-1-3-17(19)26-34-35-27(42-26)33-25(41)21-10-16(29)12-37(21)22(39)13-38-20-6-5-14(15-7-8-31-32-11-15)9-18(20)23(36-38)24(30)40/h1-9,11,16,21H,10,12-13H2,(H2,30,40)(H,33,35,41)/t16-,21+/m1/s1	DLGOXSVFDGRFJW-IERDGZPVSA-N	354216	1-(2-((2S,4R)-2-(5-(2- chlorophenyl)-1,3,4- thiadiazol-2- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 115::US10822352, Comp No. 115::US9796741, cmp No. 115	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354216	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354216&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323602	386047948							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698318	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)27(41)34-29-36-35-28(42-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,36,41)/t19-,25+/m1/s1	PVBVNNFWKNJHMU-CLOONOSVSA-N	354218	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (2-chlorophenyl)-1,3,4- thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 116::US10822352, Comp No. 116::US9796741, cmp No. 116	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354218	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354218&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323563	386047950							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698319	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nnc(s2)-c2ccc(Cl)c(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H22Cl2FN7O3S/c1-15(40)21-13-38(24-5-3-16(8-20(21)24)18-6-7-33-34-11-18)14-26(41)39-12-19(32)10-25(39)27(42)35-29-37-36-28(43-29)17-2-4-22(30)23(31)9-17/h2-9,11,13,19,25H,10,12,14H2,1H3,(H,35,37,42)/t19-,25+/m1/s1	FJFJPQGBNXXRNF-CLOONOSVSA-N	354219	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (3,4-dichlorophenyl)- 1,3,4-thiadiazol-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 117::US10822352, Comp No. 117::US9796741, cmp No. 117	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354219	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354219&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323741	386047951							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698320	CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(Br)n3)cc(C(C)=O)c2c1	InChI=1S/C28H25BrFN7O4/c1-15(38)21-13-36(22-7-6-17(8-20(21)22)18-10-31-28(32-11-18)33-16(2)39)14-26(40)37-12-19(30)9-23(37)27(41)35-25-5-3-4-24(29)34-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,34,35,41)(H,31,32,33,39)/t19-,23+/m1/s1	UWJAWFUXNVXXEN-XXBNENTESA-N	354220	(2S,4R)-1-(2-(5-(2- acetamidopyrimidin-5- yl)-3-acetyl-1H-indol- 1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 118::US10822352, Comp No. 118::US9796741, cmp No. 118	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354220	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354220&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323697	386047952							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698321	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cccc(Cl)c1	InChI=1S/C28H23BrClFN4O3/c1-16(36)22-14-34(23-9-8-18(11-21(22)23)17-4-2-5-19(30)10-17)15-27(37)35-13-20(31)12-24(35)28(38)33-26-7-3-6-25(29)32-26/h2-11,14,20,24H,12-13,15H2,1H3,(H,32,33,38)/t20-,24+/m1/s1	WIQMCFLUSFKWBO-YKSBVNFPSA-N	354221	(2S,4R)-1-(2-(3-acetyl- 5-(3-chlorophenyl)-1H- indol-1-yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 119::US10822352, Comp No. 119::US9796741, cmp No. 119	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354221	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354221&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323719	386047953							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698322	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C28H25BrFN5O3/c1-16-6-7-19(12-31-16)18-8-9-23-21(10-18)22(17(2)36)14-34(23)15-27(37)35-13-20(30)11-24(35)28(38)33-26-5-3-4-25(29)32-26/h3-10,12,14,20,24H,11,13,15H2,1-2H3,(H,32,33,38)/t20-,24+/m1/s1	VCUANRJPEFLMNS-YKSBVNFPSA-N	354222	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridin-3- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 120::US10822352, Comp No. 120::US9796741, cmp No. 120	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354222	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354222&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323689	386047954							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698323	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnnc(C)c1	InChI=1S/C34H28ClF2N5O3/c1-19-12-22(15-38-40-19)21-10-11-30-26(13-21)27(20(2)43)17-41(30)18-32(44)42-16-23(36)14-31(42)34(45)39-29-9-5-7-25(33(29)37)24-6-3-4-8-28(24)35/h3-13,15,17,23,31H,14,16,18H2,1-2H3,(H,39,45)/t23-,31+/m1/s1	OIMMHIXXLWLHLX-IPBJYNAHSA-N	354223	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridazin-4- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 121::US10822352, Comp No. 121::US9796741, cmp No. 121	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354223	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354223&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323765	386047955							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698324	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C30H30FN7O5/c1-16-9-20-22(6-8-43-28(20)25(10-16)42-2)35-30(41)24-12-19(31)14-37(24)26(39)15-38-23-4-3-17(18-5-7-33-34-13-18)11-21(23)27(36-38)29(32)40/h3-5,7,9-11,13,19,22,24H,6,8,12,14-15H2,1-2H3,(H2,32,40)(H,35,41)/t19-,22?,24+/m1/s1	LJLICBSZMAKTAW-UFGRQMGQSA-N	354224	1-(2-((2S,4R)-4-fluoro- 2-(8-methoxy-6- methylchroman-4- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 122::US10822352, Comp No. 122::US9796741, cmp No. 122	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354224	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354224&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323773	386047956							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698325	COc1cc(C)cc2C(CCOc12)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C32H32FN5O5/c1-18-10-24-26(7-9-43-31(24)29(11-18)42-3)36-32(41)28-13-22(33)15-38(28)30(40)17-37-16-25(19(2)39)23-12-20(4-5-27(23)37)21-6-8-34-35-14-21/h4-6,8,10-12,14,16,22,26,28H,7,9,13,15,17H2,1-3H3,(H,36,41)/t22-,26?,28+/m1/s1	FZHIZZJQDAZUJY-KKTWTCTJSA-N	354225	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(8-methoxy-6- methylchroman-4- yl)pyrrolidine-2- carboxamide::US10287301, Compound 123::US10822352, Comp No. 123::US9796741, cmp No. 123	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354225	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354225&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323412	386047957							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698326	Cc1ccc(F)c(c1)N1CCCC(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)C1=O	InChI=1S/C31H30F2N8O4/c1-17-4-6-22(33)25(11-17)39-10-2-3-23(31(39)45)37-30(44)26-13-20(32)15-40(26)27(42)16-41-24-7-5-18(19-8-9-35-36-14-19)12-21(24)28(38-41)29(34)43/h4-9,11-12,14,20,23,26H,2-3,10,13,15-16H2,1H3,(H2,34,43)(H,37,44)/t20-,23?,26+/m1/s1	OLXGTJSMTVWTFK-MBPASQAPSA-N	354226	1-(2-((2S,4R)-4-fluoro- 2-(1-(2-fluoro-5- methylphenyl)-2- oxopiperidin-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 124::US10822352, Comp No. 124::US9796741, cmp No. 124	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354226	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354226&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323728	386047958							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698327	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2cc(C)ccc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C33H32F2N6O4/c1-19-5-7-26(35)29(12-19)40-11-3-4-27(33(40)45)38-32(44)30-14-23(34)16-41(30)31(43)18-39-17-25(20(2)42)24-13-21(6-8-28(24)39)22-9-10-36-37-15-22/h5-10,12-13,15,17,23,27,30H,3-4,11,14,16,18H2,1-2H3,(H,38,44)/t23-,27?,30+/m1/s1	FXDUTDMEBFWTCZ-DGGRJXBFSA-N	354227	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(2-fluoro- 5-methylphenyl)-2- oxopiperidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 125::US10822352, Comp No. 125::US9796741, cmp No. 125	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354227	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354227&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323713	386047959							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698328	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)c2C(F)(F)F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H22ClF4N5O3/c1-15(39)20-13-37(23-6-5-16(9-19(20)23)17-7-8-34-35-11-17)14-25(40)38-12-18(30)10-24(38)27(41)36-22-4-2-3-21(29)26(22)28(31,32)33/h2-9,11,13,18,24H,10,12,14H2,1H3,(H,36,41)/t18-,24+/m1/s1	UDWGPDCYYCHRAY-KOSHJBKYSA-N	354228	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- chloro-2- (trifluoromethyl)phenyl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 126::US9796741, cmp No. 126	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354228	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354228&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323534	386047960							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698329	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H21BrFN7O3/c1-14(35)19-12-33(20-3-2-15(6-18(19)20)16-4-5-29-30-8-16)13-24(36)34-11-17(27)7-21(34)25(37)32-23-10-28-9-22(26)31-23/h2-6,8-10,12,17,21H,7,11,13H2,1H3,(H,31,32,37)/t17-,21+/m1/s1	QMNPPWZYTRGISQ-UTKZUKDTSA-N	354229	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(6- bromopyrazin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 127::US10822352, Comp No. 127::US9796741, cmp No. 127	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354229	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354229&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323634	386047961							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698330	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cncc(Br)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C23H19BrFN9O3/c24-18-8-27-9-19(30-18)31-23(37)17-6-14(25)10-33(17)20(35)11-34-16-2-1-12(13-3-4-28-29-7-13)5-15(16)21(32-34)22(26)36/h1-5,7-9,14,17H,6,10-11H2,(H2,26,36)(H,30,31,37)/t14-,17+/m1/s1	STTIZKZGCUGBCW-PBHICJAKSA-N	354188	1-(2-((2S,4R)-2-(5- bromopyridin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 128::US9796741, cmp No. 128::US9796741, cmp No. 90	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354188	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354188&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323639	386047920							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698331	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C28H21F4N5O5/c1-14(38)19-12-36(22-3-2-15(6-18(19)22)16-4-5-33-34-10-16)13-26(39)37-11-17(29)7-23(37)27(40)35-21-9-25-24(8-20(21)30)41-28(31,32)42-25/h2-6,8-10,12,17,23H,7,11,13H2,1H3,(H,35,40)/t17-,23+/m1/s1	LVSKWPPYMYQIBU-HXOBKFHXSA-N	354231	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2,2,6- trifluorobenzo[d][1,3] dioxol-5-yl)pyrrolidine- 2-carboxamide::US10822352, Comp No. 129::US9796741, cmp No. 129	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354231	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354231&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323548	386047962							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698332	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc3OC(F)(F)Oc3cc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H19F4N7O5/c27-14-6-19(25(40)34-17-8-21-20(7-16(17)28)41-26(29,30)42-21)36(10-14)22(38)11-37-18-2-1-12(13-3-4-32-33-9-13)5-15(18)23(35-37)24(31)39/h1-5,7-9,14,19H,6,10-11H2,(H2,31,39)(H,34,40)/t14-,19+/m1/s1	LOAHZBPECSIMPS-KUHUBIRLSA-N	354232	1-(2-((2S,4R)-4-fluoro- 2-(2,2,6- trifluorobenzo[d][1,3] dioxol-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10822352, Comp No. 130::US9796741, cmp No. 130	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354232	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354232&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323756	386047963							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698333	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3ccccc3c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H24FN7O3/c30-21-13-25(29(40)34-22-7-5-17-3-1-2-4-18(17)11-22)36(15-21)26(38)16-37-24-8-6-19(20-9-10-32-33-14-20)12-23(24)27(35-37)28(31)39/h1-12,14,21,25H,13,15-16H2,(H2,31,39)(H,34,40)/t21-,25+/m1/s1	PJCNYXBQSWMAOG-BWKNWUBXSA-N	354233	1-(2-((2S,4R)-4-fluoro- 2-(naphthalen-2- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 131::US10822352, Comp No. 131::US9796741, cmp No. 131	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354233	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354233&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323774	386047964							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698334	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C28H25BrN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)19-11-30-16(2)31-12-19)14-27(37)35-23-9-18(23)10-24(35)28(38)33-26-5-3-4-25(29)32-26/h3-8,11-13,18,23-24H,9-10,14H2,1-2H3,(H,32,33,38)/t18-,23-,24+/m1/s1	VDORKYXTVASCJK-QFWMQHCXSA-N	354234	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(6-bromopyridin-2- yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 132::US10822352, Comp No. 132::US9796741, cmp No. 132	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354234	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354234&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323588	386047965							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698335	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C35H29ClFN5O3/c1-19(43)27-17-41(30-11-10-21(12-26(27)30)23-15-38-20(2)39-16-23)18-33(44)42-31-13-22(31)14-32(42)35(45)40-29-9-5-7-25(34(29)37)24-6-3-4-8-28(24)36/h3-12,15-17,22,31-32H,13-14,18H2,1-2H3,(H,40,45)/t22-,31-,32+/m1/s1	BRAAMOHBRUGSOM-MMFLPWJGSA-N	354236	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3-yl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 133::US10822352, Comp No. 133::US9796741, cmp No. 133	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354236	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354236&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323660	386047967							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698336	CC(=O)c1cn(CC(=O)N2[C@@H]3C[C@@H]3C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C30H27ClFN5O3/c1-16(38)23-14-36(25-7-6-18(8-22(23)25)21-12-33-17(2)34-13-21)15-28(39)37-26-9-20(26)10-27(37)30(40)35-11-19-4-3-5-24(31)29(19)32/h3-8,12-14,20,26-27H,9-11,15H2,1-2H3,(H,35,40)/t20-,26-,27+/m1/s1	KJFCNCXMENHIRF-UIFDUCBYSA-N	354237	(1R,3S,5R)-2-(2-(3- acetyl-5-(2- methylpyrimidin-5-yl)- 1H-indol-1-yl)acetyl)- N-(3-chloro-2- fluorobenzyl)-2- azabicyclo[3.1.0] hexane-3-carboxamide::US10287301, Compound 134::US10822352, Comp No. 134::US9796741, cmp No. 134	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354237	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354237&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323643	386047968							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698337	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2cccc(Cl)c2F)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C29H26ClF2N5O3/c1-16(38)23-14-36(25-7-6-18(8-22(23)25)20-11-33-17(2)34-12-20)15-27(39)37-13-21(31)9-26(37)29(40)35-10-19-4-3-5-24(30)28(19)32/h3-8,11-12,14,21,26H,9-10,13,15H2,1-2H3,(H,35,40)/t21-,26+/m1/s1	JHHLIMNNIQOCGJ-RLWLMLJZSA-N	354238	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 135::US10822352, Comp No. 135::US9796741, cmp No. 135	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354238	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354238&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323543	386047969							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698338	COc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)NCc3cccc(Cl)c3F)cc(C(C)=O)c2c1	InChI=1S/C29H26ClF2N5O4/c1-16(38)22-14-36(24-7-6-17(8-21(22)24)19-11-34-29(41-2)35-12-19)15-26(39)37-13-20(31)9-25(37)28(40)33-10-18-4-3-5-23(30)27(18)32/h3-8,11-12,14,20,25H,9-10,13,15H2,1-2H3,(H,33,40)/t20-,25+/m1/s1	AMLVMZDJOUXHNX-NLFFAJNJSA-N	354239	(2S,4R)-1-(2-(3-acetyl- 5-(2- methoxypyrimidin-5- yl)-1H-indol-1- yl)acetyl)-N-(3-chloro- 2-fluorobenzyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 136::US10822352, Comp No. 136::US9796741, cmp No. 136	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354239	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354239&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323573	386047970							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698339	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Cl)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C27H24ClFN6O3/c1-15(36)21-13-34(22-7-6-17(8-20(21)22)18-10-30-16(2)31-11-18)14-26(37)35-12-19(29)9-23(35)27(38)33-25-5-3-4-24(28)32-25/h3-8,10-11,13,19,23H,9,12,14H2,1-2H3,(H,32,33,38)/t19-,23+/m1/s1	BZKVXKLDHVUFKO-XXBNENTESA-N	354240	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(6- chloropyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 137::US10822352, Comp No. 137::US9796741, cmp No. 137	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354240	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354240&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323536	386047971							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698340	CC(=O)Nc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C35H29ClF2N6O4/c1-19(45)27-17-43(30-11-10-21(12-26(27)30)22-14-39-35(40-15-22)41-20(2)46)18-32(47)44-16-23(37)13-31(44)34(48)42-29-9-5-7-25(33(29)38)24-6-3-4-8-28(24)36/h3-12,14-15,17,23,31H,13,16,18H2,1-2H3,(H,42,48)(H,39,40,41,46)/t23-,31+/m1/s1	ZUEHMKHQIJZEEW-IPBJYNAHSA-N	354241	(2S,4R)-1-(2-(5-(2- acetamidopyrimidin-5- yl)-3-acetyl-1H-indol- 1-yl)acetyl)-N-(2'- chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 138::US10822352, Comp No. 138::US9796741, cmp No. 138	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354241	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354241&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323661	386047972							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698341	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-17-10-21(25(37)29-12-18-3-1-2-7-28-18)33(13-17)22(35)14-34-20-5-4-15(16-6-8-30-31-11-16)9-19(20)23(32-34)24(27)36/h1-9,11,17,21H,10,12-14H2,(H2,27,36)(H,29,37)/t17-,21+/m1/s1	ZMOUVYBPXIBHNS-UTKZUKDTSA-N	354242	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-2- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 139::US10822352, Comp No. 139::US9796741, cmp No. 139	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354242	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354242&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323737	386047973							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698342	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2)c2cnn(C)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H33FN8O3/c1-19(40)26-17-38(27-6-5-20(10-25(26)27)21-7-8-32-33-12-21)18-29(41)39-14-22(31)11-28(39)30(42)35-23-4-3-9-37(15-23)24-13-34-36(2)16-24/h5-8,10,12-13,16-17,22-23,28H,3-4,9,11,14-15,18H2,1-2H3,(H,35,42)/t22-,23?,28+/m1/s1	PTTPIJSBFUGWMI-XFILVABKSA-N	354243	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(1-methyl- 1H-pyrazol-4- yl)piperidin-3- yl)pyrrolidine-2- carboxamide::US10287301, Compound 140::US10822352, Comp No. 140::US9796741, cmp No. 140	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354243	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354243&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323600	386047974							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698343	Cn1cc(cn1)N1CCCC(C1)NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1nc(C(N)=O)c2cc(ccc12)-c1ccnnc1	InChI=1S/C28H31FN10O3/c1-36-15-21(12-33-36)37-8-2-3-20(14-37)34-28(42)24-10-19(29)13-38(24)25(40)16-39-23-5-4-17(18-6-7-31-32-11-18)9-22(23)26(35-39)27(30)41/h4-7,9,11-12,15,19-20,24H,2-3,8,10,13-14,16H2,1H3,(H2,30,41)(H,34,42)/t19-,20?,24+/m1/s1	MCBXXXNHKNEFJF-JATBYWIBSA-N	354244	1-(2-((2S,4R)-4-fluoro- 2-(1-(1-methyl-1H- pyrazol-4-yl)piperidin- 3-ylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 141::US10822352, Comp No. 141::US9796741, cmp No. 141	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354244	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354244&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323529	386047975							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698344	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2ccc3cn[nH]c3c2)c2ccc(cc12)-c1ccnnc1			354245	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1H-indazol- 6-yl)pyrrolidine-2- carboxamide::US10287301, Compound 142::US10822352, Comp No. 142::US9796741, cmp No. 142	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354245	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354245&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208187	386047976							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698345	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCC[C@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H28FN5O4/c1-15(33)20-13-31(22-6-5-16(9-19(20)22)17-7-8-28-29-11-17)14-25(35)32-12-18(27)10-23(32)26(36)30-21-3-2-4-24(21)34/h5-9,11,13,18,21,23-24,34H,2-4,10,12,14H2,1H3,(H,30,36)/t18-,21-,23+,24-/m1/s1	JDFXREZXKVJIOX-OLOOCYQZSA-N	354246	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-((1R,2R)-2- hydroxycyclopentyl) pyrrolidine-2- carboxamide::US10287301, Compound 143::US10822352, Comp No. 143::US9796741, cmp No. 143	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354246	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354246&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323550	386047977							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698346	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(O)n2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C26H23FN6O4/c1-15(34)20-13-32(21-6-5-16(9-19(20)21)17-7-8-28-29-11-17)14-25(36)33-12-18(27)10-22(33)26(37)31-23-3-2-4-24(35)30-23/h2-9,11,13,18,22H,10,12,14H2,1H3,(H2,30,31,35,37)/t18-,22+/m1/s1	HURUMVQSEGPJGQ-GCJKJVERSA-N	354247	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(6- hydroxypyridin-2- yl)pyrrolidine-2- carboxamide::US10287301, Compound 144::US10822352, Comp No. 144::US9796741, cmp No. 144	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354247	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354247&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323591	386047978							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698347	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)N[C@@H]2CCC[C@H]2O)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H26FN7O4/c25-15-9-19(24(36)29-17-2-1-3-20(17)33)31(11-15)21(34)12-32-18-5-4-13(14-6-7-27-28-10-14)8-16(18)22(30-32)23(26)35/h4-8,10,15,17,19-20,33H,1-3,9,11-12H2,(H2,26,35)(H,29,36)/t15-,17-,19+,20-/m1/s1	NTKMUBWYJKVCJW-WSTLGDPDSA-N	354248	1-(2-((2S,4R)-4-fluoro- 2-((1R,2R)-2- hydroxycyclopentyl- carbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 145::US10822352, Comp No. 145::US9796741, cmp No. 145	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354248	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354248&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323605	386047979							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698348	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C27H21ClFN9O3S/c28-17-3-1-2-15(8-17)25-33-27(42-36-25)34-26(41)21-10-18(29)12-37(21)22(39)13-38-20-5-4-14(16-6-7-31-32-11-16)9-19(20)23(35-38)24(30)40/h1-9,11,18,21H,10,12-13H2,(H2,30,40)(H,33,34,36,41)/t18-,21+/m1/s1	PBMTXPKHSJNECA-NQIIRXRSSA-N	354249	1-(2-((2S,4R)-2-(3-(3- chlorophenyl)-1,2,4- thiadiazol-5- ylcarbamoyl)-4- fluoropyrrolidin-l-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 146::US10822352, Comp No. 146::US9796741, cmp No. 146	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354249	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354249&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323678	386047980							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698349	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2nc(ns2)-c2cccc(Cl)c2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O3S/c1-16(39)23-14-37(24-6-5-17(10-22(23)24)19-7-8-32-33-12-19)15-26(40)38-13-21(31)11-25(38)28(41)35-29-34-27(36-42-29)18-3-2-4-20(30)9-18/h2-10,12,14,21,25H,11,13,15H2,1H3,(H,34,35,36,41)/t21-,25+/m1/s1	YYWGWXVFYLDSKE-BWKNWUBXSA-N	354250	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (3-chlorophenyl)-1,2,4- thiadiazol-5-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 147::US10822352, Comp No. 147::US9796741, cmp No. 147	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354250	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354250&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323637	386047981							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698350	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1ccc(C)nn1	InChI=1S/C27H24BrFN6O3/c1-15-6-8-21(33-32-15)17-7-9-22-19(10-17)20(16(2)36)13-34(22)14-26(37)35-12-18(29)11-23(35)27(38)31-25-5-3-4-24(28)30-25/h3-10,13,18,23H,11-12,14H2,1-2H3,(H,30,31,38)/t18-,23+/m1/s1	XINDJMGEVZSWEF-JPYJTQIMSA-N	354251	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridazin-3- yl)-1H-indol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 148::US10822352, Comp No. 148::US9796741, cmp No. 148	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354251	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354251&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323672	386047982							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698351	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2Cl)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H28Cl2FN5O3/c1-19(43)27-17-41(30-11-10-21(12-26(27)30)22-14-38-20(2)39-15-22)18-32(44)42-16-23(37)13-31(42)34(45)40-29-9-5-7-25(33(29)36)24-6-3-4-8-28(24)35/h3-12,14-15,17,23,31H,13,16,18H2,1-2H3,(H,40,45)/t23-,31+/m1/s1	JWCUHZPLBFUBKM-IPBJYNAHSA-N	354252	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2,2'- dichlorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US9796741, cmp No. 149	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354252	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354252&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323616	386047983							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698352	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2cc(F)c(F)cc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C34H26ClF4N5O3/c1-17(45)25-15-43(30-7-6-19(8-24(25)30)20-12-40-18(2)41-13-20)16-32(46)44-14-21(36)9-31(44)34(47)42-29-5-3-4-22(33(29)39)23-10-27(37)28(38)11-26(23)35/h3-8,10-13,15,21,31H,9,14,16H2,1-2H3,(H,42,47)/t21-,31+/m1/s1	XMOIWBPMHZVMQJ-UKPGIYTDSA-N	354253	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2,4',5'- trifluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 150::US9796741, cmp No. 150	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354253	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354253&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323547	386047984							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698353	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1ccc(C)nc1	InChI=1S/C35H29ClF2N4O3/c1-20-10-11-23(16-39-20)22-12-13-31-27(14-22)28(21(2)43)18-41(31)19-33(44)42-17-24(37)15-32(42)35(45)40-30-9-5-7-26(34(30)38)25-6-3-4-8-29(25)36/h3-14,16,18,24,32H,15,17,19H2,1-2H3,(H,40,45)/t24-,32+/m1/s1	KEUSTPZVQDYRHT-QNLPTKCRSA-N	354254	(2S,4R)-1-(2-(3-acetyl- 5-(6-methylpyridin-3- yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 151::US10822352, Comp No. 151::US9796741, cmp No. 151	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354254	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354254&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323544	386047985							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698354	CC1Oc2cccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3nc(C(N)=O)c4cc(ccc34)-c3ccnnc3)c2NC1=O	InChI=1S/C28H25FN8O5/c1-14-27(40)34-25-19(3-2-4-22(25)42-14)33-28(41)21-10-17(29)12-36(21)23(38)13-37-20-6-5-15(16-7-8-31-32-11-16)9-18(20)24(35-37)26(30)39/h2-9,11,14,17,21H,10,12-13H2,1H3,(H2,30,39)(H,33,41)(H,34,40)/t14?,17-,21+/m1/s1	VBIMXRCJVBIUJR-ZFXWJCKASA-N	354255	1-(2-((2S,4R)-4-fluoro- 2-(2-methyl-3-oxo-3,4- dihydro-2H- benzo[b][1,4]oxazin-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 152::US10822352, Comp No. 152::US9796741, cmp No. 152	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354255	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354255&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323619	386047986							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698355	CC1Oc2cccc(NC(=O)[C@@H]3C[C@@H](F)CN3C(=O)Cn3cc(C(C)=O)c4cc(ccc34)-c3ccnnc3)c2NC1=O	InChI=1S/C30H27FN6O5/c1-16(38)22-14-36(24-7-6-18(10-21(22)24)19-8-9-32-33-12-19)15-27(39)37-13-20(31)11-25(37)30(41)34-23-4-3-5-26-28(23)35-29(40)17(2)42-26/h3-10,12,14,17,20,25H,11,13,15H2,1-2H3,(H,34,41)(H,35,40)/t17?,20-,25+/m1/s1	DNWBYAOOZUCOPM-SPGLARIMSA-N	354256	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(2-methyl-3- oxo-3,4-dihydro-2H- benzo[b][1,4]oxazin-5- yl)pyrrolidine-2- carboxamide::US10287301, Compound 153::US10822352, Comp No. 153::US9796741, cmp No. 153	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354256	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354256&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323614	386047987							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698356	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cc(O)ccn2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C24H21FN8O4/c25-15-8-19(24(37)30-20-9-16(34)4-5-27-20)32(11-15)21(35)12-33-18-2-1-13(14-3-6-28-29-10-14)7-17(18)22(31-33)23(26)36/h1-7,9-10,15,19H,8,11-12H2,(H2,26,36)(H2,27,30,34,37)/t15-,19+/m1/s1	NALNFESPHXYTFN-BEFAXECRSA-N	354257	1-(2-((2S,4R)-4-fluoro- 2-(4-hydroxypyridin-2- ylcarbamoyl)pyrrolidin- l-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 154::US10822352, Comp No. 154::US9796741, cmp No. 154	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354257	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354257&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323487	386047988							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698357	Cn1ccc(n1)N1CCC(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)C1=O	InChI=1S/C27H27FN10O4/c1-35-8-6-22(33-35)36-9-5-19(27(36)42)32-26(41)21-11-17(28)13-37(21)23(39)14-38-20-3-2-15(16-4-7-30-31-12-16)10-18(20)24(34-38)25(29)40/h2-4,6-8,10,12,17,19,21H,5,9,11,13-14H2,1H3,(H2,29,40)(H,32,41)/t17-,19?,21+/m1/s1	BFENFBFUUOJGHY-INMVSHNGSA-N	354258	1-(2-((2S,4R)-4-fluoro- 2-(1-(1-methyl-1H- pyrazol-3-yl)-2- oxopyrrolidin-3- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 155::US10822352, Comp No. 155::US9796741, cmp No. 155	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354258	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354258&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323720	386047989							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698358	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2c[nH]nc2-c2ccc(Cl)cc2Cl)c2ccc(cc12)-c1ccnnc1			354259	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(3- (2,4-dichlorophenyl)- 1H-pyrazol-4-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 156::US10822352, Comp No. 156::US9796741, cmp No. 156	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354259	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354259&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			139208188	386047990							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698359	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NCc2ccncc2)c2ccc(cc12)-c1ccnnc1	InChI=1S/C25H23FN8O3/c26-18-10-21(25(37)29-11-15-3-6-28-7-4-15)33(13-18)22(35)14-34-20-2-1-16(17-5-8-30-31-12-17)9-19(20)23(32-34)24(27)36/h1-9,12,18,21H,10-11,13-14H2,(H2,27,36)(H,29,37)/t18-,21+/m1/s1	GJCXNCCSWFAZFH-NQIIRXRSSA-N	354260	1-(2-((2S,4R)-4-fluoro- 2-(pyridin-4- ylmethylcarbamoyl) pyrrolidin-1-yl)-2- oxoethyl)-5-(pyridazin- 4-yl)-1H-indazole-3- carboxamide::US10287301, Compound 157::US10822352, Comp No. 157::US9796741, cmp No. 157	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354260	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354260&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323732	386047991							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698360	Cc1cc(NC(=O)[C@@H]2C[C@@H](F)CN2C(=O)Cn2nc(C(N)=O)c3cc(ccc23)-c2ccnnc2)n(n1)-c1ccccc1F	InChI=1S/C29H25F2N9O3/c1-16-10-25(40(36-16)23-5-3-2-4-21(23)31)35-29(43)24-12-19(30)14-38(24)26(41)15-39-22-7-6-17(18-8-9-33-34-13-18)11-20(22)27(37-39)28(32)42/h2-11,13,19,24H,12,14-15H2,1H3,(H2,32,42)(H,35,43)/t19-,24+/m1/s1	AZNXFDFEWRKYIZ-DVECYGJZSA-N	354261	1-(2-((2S,4R)-4-fluoro- 2-(1-(2-fluorophenyl)- 3-methyl-1H-pyrazol-5- ylcarbamoyl)pyrrolidin- 1-yl)-2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 158::US10822352, Comp No. 158::US9796741, cmp No. 158	Complement factor D	Human		>10000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354261	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354261&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323586	386047992							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698361	NC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C30H28ClFN8O4/c31-21-4-1-2-6-24(21)38-11-3-5-22(30(38)44)36-29(43)25-13-19(32)15-39(25)26(41)16-40-23-8-7-17(18-9-10-34-35-14-18)12-20(23)27(37-40)28(33)42/h1-2,4,6-10,12,14,19,22,25H,3,5,11,13,15-16H2,(H2,33,42)(H,36,43)/t19-,22?,25+/m1/s1	HMCWLTLTHIKDHQ-CGPDNSSVSA-N	354262	1-(2-((2S,4R)-2-(1-(2- chlorophenyl)-2- oxopiperidin-3- ylcarbamoyl)-4- fluoropyrrolidin-1-yl)- 2-oxoethyl)-5- (pyridazin-4-yl)-1H- indazole-3-carboxamide::US10287301, Compound 159::US10822352, Comp No. 159::US9796741, cmp No. 159	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354262	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354262&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323628	386047993							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698362	CC(=O)c1cn(CC(=O)C2C[C@H](F)C[C@H]2C(=O)Nc2cc(C)nn2-c2ccccc2F)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H28F2N6O3/c1-18-11-31(40(38-18)29-6-4-3-5-27(29)34)37-32(43)25-14-22(33)13-24(25)30(42)17-39-16-26(19(2)41)23-12-20(7-8-28(23)39)21-9-10-35-36-15-21/h3-12,15-16,22,24-25H,13-14,17H2,1-2H3,(H,37,43)/t22-,24?,25+/m0/s1	YGDUZNJUHFKWIB-DEWJTGPOSA-N	354263	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(2- fluorophenyl)-3- methyl-1H-pyrazol-5- yl)pyrrolidine-2- carboxamide::US9796741, cmp No. 160	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354263	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354263&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			132033910	386047994							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698363	CC(=O)c1cn(CC(=O)N2C[C@@H](F)C[C@@H]2C(=O)NC2CCCN(C2=O)c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C32H30ClFN6O4/c1-19(41)24-17-38(27-9-8-20(13-23(24)27)21-10-11-35-36-15-21)18-30(42)40-16-22(34)14-29(40)31(43)37-26-6-4-12-39(32(26)44)28-7-3-2-5-25(28)33/h2-3,5,7-11,13,15,17,22,26,29H,4,6,12,14,16,18H2,1H3,(H,37,43)/t22-,26?,29+/m0/s1	MVUMCWSPWBWAED-PWMFPERWSA-N	354264	(2R,4S)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(1- (2-chlorophenyl)-2- oxopiperidin-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 161::US10822352, Comp No. 161::US9796741, cmp No. 161	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354264	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354264&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323523	386047995							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698364	CC(NC(=O)[C@@H]1C[C@@H](F)CN1C(=O)Cn1cc(C(C)=O)c2cc(ccc12)-c1ccnnc1)c1oc2ccc(F)cc2c1C	InChI=1S/C32H29F2N5O4/c1-17-24-11-22(33)5-7-29(24)43-31(17)18(2)37-32(42)28-12-23(34)14-39(28)30(41)16-38-15-26(19(3)40)25-10-20(4-6-27(25)38)21-8-9-35-36-13-21/h4-11,13,15,18,23,28H,12,14,16H2,1-3H3,(H,37,42)/t18?,23-,28+/m1/s1	PVDFVXKXFOCKJE-APRMAWDYSA-N	354265	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-4- fluoro-N-(1-(5-fluoro- 3-methylbenzofuran-2- yl)ethyl)pyrrolidine-2- carboxamide::US10287301, Compound 162::US10822352, Comp No. 162::US9796741, cmp No. 162	Complement factor D	Human		 5050							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354265	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354265&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323533	386047996							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698365	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)32-25-12-20(21-14-37-19(2)38-15-21)10-11-28(25)42(40-32)17-30(44)41-16-22(35)13-29(41)33(45)39-27-9-5-7-24(31(27)36)23-6-3-4-8-26(23)34/h3-12,14-15,22,29H,13,16-17H2,1-2H3,(H,39,45)/t22-,29+/m1/s1	IBAALFJDCTWVJH-MNNSJKJDSA-N	354266	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10822352, Comp No. 163::US9796741, cmp No. 163	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354266	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354266&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323500	386047997							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698366	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ncccc2Cl)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C33H27ClF2N6O3/c1-18(43)25-16-41(28-9-8-20(11-24(25)28)21-13-38-19(2)39-14-21)17-30(44)42-15-22(35)12-29(42)33(45)40-27-7-3-5-23(31(27)36)32-26(34)6-4-10-37-32/h3-11,13-14,16,22,29H,12,15,17H2,1-2H3,(H,40,45)/t22-,29+/m1/s1	NDFKWKHKSOGTII-MNNSJKJDSA-N	354267	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(3-(3- chloropyridin-2-yl)-2- fluorophenyl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 164::US10822352, Comp No. 164::US9796741, cmp No. 164	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354267	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354267&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323701	386047998							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698367	CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(Br)n2)c2ccc(cc12)-c1cnc(C)nc1	InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1	PIBARDGJJAGJAJ-NQIIRXRSSA-N	354268	(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 165::US10822352, Comp No. 165::US9796741, cmp No. 165	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354268	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354268&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323590	386047999							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698368	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2noc(n2)-c2ccccc2Cl)c2ccc(cc12)-c1ccnnc1	InChI=1S/C29H23ClFN7O4/c1-16(39)22-14-37(24-7-6-17(10-21(22)24)18-8-9-32-33-12-18)15-26(40)38-13-19(31)11-25(38)27(41)34-29-35-28(42-36-29)20-4-2-3-5-23(20)30/h2-10,12,14,19,25H,11,13,15H2,1H3,(H,34,36,41)/t19-,25+/m1/s1	QZJGDLXBYUTUBH-CLOONOSVSA-N	354269	(2S,4R)-1-(2-(3-acetyl- 5-(pyridazin-4-yl)-1H- indol-1-yl)acetyl)-N-(5- (2-chlorophenyl)-1,2,4- oxadiazol-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 182::US10822352, Comp No. 182::US9796741, cmp No. 182	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354269	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354269&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323711	386048000							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698369	CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(O)nc1	InChI=1S/C33H26ClF2N5O4/c1-18(42)25-16-40(28-10-9-19(11-24(25)28)20-13-37-33(45)38-14-20)17-30(43)41-15-21(35)12-29(41)32(44)39-27-8-4-6-23(31(27)36)22-5-2-3-7-26(22)34/h2-11,13-14,16,21,29H,12,15,17H2,1H3,(H,39,44)(H,37,38,45)/t21-,29+/m1/s1	RWJNYEKDPREUGN-PBBNMVCDSA-N	354270	(2S,4R)-1-(2-(3-acetyl- 5-(2-hydroxypyrimidin- 5-yl)-1H-indol-1- yl)acetyl)-N-(2'-chloro- 2-fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 186::US10822352, Comp No. 186::US9796741, cmp No. 186	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354270	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354270&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323433	386048001							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698370	COCCNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C36H33ClF2N6O4/c1-21(46)28-19-44(31-11-10-22(14-27(28)31)23-16-41-36(42-17-23)40-12-13-49-2)20-33(47)45-18-24(38)15-32(45)35(48)43-30-9-5-7-26(34(30)39)25-6-3-4-8-29(25)37/h3-11,14,16-17,19,24,32H,12-13,15,18,20H2,1-2H3,(H,43,48)(H,40,41,42)/t24-,32+/m1/s1	RGRXXQWTHFRHCF-QNLPTKCRSA-N	354271	(2S,4R)-1-(2-(3-acetyl- 5-(2-(2- methoxyethylamino) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide::US10287301, Compound 187::US10822352, Comp No. 187::US9796741, cmp No. 187	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354271	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354271&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323428	386048002							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
698371	CNc1ncc(cn1)-c1ccc2n(CC(=O)N3C[C@H](F)C[C@H]3C(=O)Nc3cccc(c3F)-c3ccccc3Cl)cc(C(C)=O)c2c1	InChI=1S/C34H29ClF2N6O3/c1-19(44)26-17-42(29-11-10-20(12-25(26)29)21-14-39-34(38-2)40-15-21)18-31(45)43-16-22(36)13-30(43)33(46)41-28-9-5-7-24(32(28)37)23-6-3-4-8-27(23)35/h3-12,14-15,17,22,30H,13,16,18H2,1-2H3,(H,41,46)(H,38,39,40)/t22-,30+/m1/s1	UHTFHXXYAAMHRH-RCRUUEGKSA-N	354272	(2S,4R)-1-(2-(3-acetyl- 5-(2-(methylamino) pyrimidin-5-yl)-1H- indol-1-yl)acetyl)- N-(2'-chloro-2- fluorobiphenyl-3-yl)- 4-fluoropyrrolidine-2- carboxamide::US10287301, Compound 188::US10822352, Comp No. 188::US9796741, cmp No. 188	Complement factor D	Human		<1000							US Patent		10.7270/Q2QN68XC		aid1797527	US9796741	Gadhachanda, VR; Wang, Q; Pais, G; Hashimoto, A; Chen, D; Wang, X; Agarwal, A; Deshpande, M; Wiles, JA; Phadke, AS	10/24/2017	9/23/2019	Achillion Pharmaceuticals Inc	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=354272	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7500&target=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=354272&enzyme=Complement+factor+D&column=ki&startPg=0&Increment=50&submit=Search			118323520	386048003							1	MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA	1DFP,1DIC,1DSU,1FDP,1HFD,4D9R,5FBE,5FBI,5FCK,5MT0,5MT4,5NAR,5NAT,5NAW,5NB6,5NB7,5NBA,5TCA,5TCC,6FTY,6FTZ,6FUG,6FUH,6FUI,6FUJ,6FUT,6QMR,6QMT,6VMJ,6VMK,8D95,8DEA,8DG6	Complement factor D	CFAD_HUMAN	P00746	B4DV76 Q5U5S1 Q86VJ5 Q8N4E0 Q8WZB4